ATE187083T1 - Verfahren für nadellose subkutaninjektionen - Google Patents

Verfahren für nadellose subkutaninjektionen

Info

Publication number: ATE187083T1
Authority: AT; Austria
Prior art keywords: reservoir; ampule; poppet valve; gas; pressure
Prior art date: 1992-07-24

Application number

AT93918344T

Other languages

English (en)

Inventor

Steven Fisher Peterson

Charles Neal Mckinnon Jr

Paul Edward Smith

Takaaki Nakagawa

Victor Leon Bartholomew

Original Assignee

Bioject Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-24

Filing date

1993-07-23

Publication date

1999-12-15

1993-07-23 Application filed by Bioject Inc filed Critical Bioject Inc

1999-12-15 Application granted granted Critical

1999-12-15 Publication of ATE187083T1 publication Critical patent/ATE187083T1/de

Links

238000000034 method Methods 0.000 title abstract 2
239000007929 subcutaneous injection Substances 0.000 title 1
239000003708 ampul Substances 0.000 abstract 4
238000002347 injection Methods 0.000 abstract 3
239000007924 injection Substances 0.000 abstract 3
239000003999 initiator Substances 0.000 abstract 2
238000005336 cracking Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31516—Piston or piston-rod constructions, e.g. connection of piston with piston-rod reducing dead-space in the syringe barrel after delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum

Landscapes

Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

AT93918344T 1992-07-24 1993-07-23 Verfahren für nadellose subkutaninjektionen ATE187083T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/920,106 US5383851A (en)	1992-07-24	1992-07-24	Needleless hypodermic injection device

Publications (1)

Publication Number	Publication Date
ATE187083T1 true ATE187083T1 (de)	1999-12-15

Family

ID=25443171

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93918344T ATE187083T1 (de)	1992-07-24	1993-07-23	Verfahren für nadellose subkutaninjektionen

Country Status (8)

Country	Link
US (3)	US5383851A (de)
EP (1)	EP0651663B1 (de)
JP (2)	JP3633615B2 (de)
AT (1)	ATE187083T1 (de)
AU (1)	AU676490B2 (de)
CA (1)	CA2140772C (de)
DE (1)	DE69327165T2 (de)
WO (1)	WO1994002188A1 (de)

Families Citing this family (1185)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2689017B1 (fr) *	1992-03-31	1994-05-27	Mtc Medical	Appareil d'injection medicale ou veterinaire.
US5383851A (en) *	1992-07-24	1995-01-24	Bioject Inc.	Needleless hypodermic injection device
US5405333A (en) *	1992-12-28	1995-04-11	Richmond; Frank M.	Liquid medicament bag with needleless connector fitting using boat assembly
US6206860B1 (en)	1993-07-28	2001-03-27	Frank M. Richmond	Spikeless connection and drip chamber with valve
US5540657A (en) *	1994-07-15	1996-07-30	Collagen Corporation	Delivery device for injectable materials
DE19519279A1 (de) *	1994-12-07	1996-08-22	Wolfgang Dr Med Wagner	Verfahren und Einrichtung zur Saug-Druckinjektion
US5599302A (en)	1995-01-09	1997-02-04	Medi-Ject Corporation	Medical injection system and method, gas spring thereof and launching device using gas spring
DE29507987U1 (de) *	1995-05-15	1996-09-19	Ferton Holding, Delemont	Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
US5893397A (en) *	1996-01-12	1999-04-13	Bioject Inc.	Medication vial/syringe liquid-transfer apparatus
US5697917A (en)	1996-02-29	1997-12-16	Medi-Ject Corporation	Nozzle assembly with adjustable plunger travel gap
US5921967A (en)	1996-02-29	1999-07-13	Medi-Ject Corporation	Plunger for nozzle assembly
US5643211A (en)	1996-02-29	1997-07-01	Medi-Ject Corporation	Nozzle assembly having a frangible plunger
US5722953A (en)	1996-02-29	1998-03-03	Medi-Ject Corporation	Nozzle assembly for injection device
US5865795A (en)	1996-02-29	1999-02-02	Medi-Ject Corporation	Safety mechanism for injection devices
US5800388A (en)	1996-02-29	1998-09-01	Medi-Ject Corporation	Plunger/ram assembly adapted for a fluid injector
US5785688A (en) *	1996-05-07	1998-07-28	Ceramatec, Inc.	Fluid delivery apparatus and method
PL186641B1 (pl)	1996-07-01	2004-02-27	Pharmacia Ab	Sposób i urządzenie do dostarczania preparatu
US6458574B1 (en)	1996-09-12	2002-10-01	Transkaryotic Therapies, Inc.	Treatment of a α-galactosidase a deficiency
US6106502A (en) *	1996-12-18	2000-08-22	Richmond; Frank M.	IV sets with needleless fittings and valves
US5875976A (en)	1996-12-24	1999-03-02	Medi-Ject Corporation	Locking mechanism for nozzle assembly
US5993412A (en) *	1997-05-19	1999-11-30	Bioject, Inc.	Injection apparatus
US5911703A (en) *	1997-05-22	1999-06-15	Avant Drug Delivery Systems, Inc.	Two-stage fluid medicament jet injector
US5947928A (en) *	1997-06-19	1999-09-07	Mile Creek Capital, Llc	Drug delivery system
USD399951S (en)	1997-06-30	1998-10-20	Bioject, Inc.	Injection apparatus
US5964735A (en) *	1997-07-01	1999-10-12	Medisys Technologies, Inc.	Fine needle aspiration safety syringe
EP0888790A1 (de) *	1997-07-04	1999-01-07	PowderJect Research Limited	Vorrichtung zur Abgabe von Medikamententeilchen
US6569127B1 (en) *	1997-07-18	2003-05-27	Liebel-Flarsheim Company	Adapter and syringe for front-loading medical fluid injector
US6171276B1 (en)	1997-08-06	2001-01-09	Pharmacia & Upjohn Ab	Automated delivery device and method for its operation
US6071272A (en) *	1997-10-28	2000-06-06	Hoffman; Alan S.	Method for treating erectile dysfunctionality
US6610042B2 (en)	1997-12-05	2003-08-26	Felton Medical, Inc.	Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
US6541606B2 (en) *	1997-12-31	2003-04-01	Altus Biologics Inc.	Stabilized protein crystals formulations containing them and methods of making them
US5993418A (en) *	1998-02-24	1999-11-30	Medisys Technologies, Inc.	Safety syringe
US20020147143A1 (en)	1998-03-18	2002-10-10	Corixa Corporation	Compositions and methods for the therapy and diagnosis of lung cancer
JP2002511396A (ja)	1998-04-14	2002-04-16	メルクエンドカムパニーインコーポレーテッド	ポリヌクレオチド製剤の無針投与
CN1651103A (zh)	1998-07-27	2005-08-10	安塔雷斯药品公司	一种注射装置
US6123684A (en) *	1998-07-27	2000-09-26	Medi-Ject Corporation	Loading mechanism for medical injector assembly
GB9818110D0 (en) *	1998-08-19	1998-10-14	Weston Medical Ltd	Needleless injectors and other devices
DE69921489T2 (de)	1998-08-31	2005-10-27	Johnson & Johnson Consumer Companies, Inc.	Elektrotransportvorrichtung mit klingen
US20030235557A1 (en)	1998-09-30	2003-12-25	Corixa Corporation	Compositions and methods for WT1 specific immunotherapy
US6783509B1 (en)	1998-11-18	2004-08-31	Bioject Inc.	Single-use needle-less hypodermic jet injection apparatus and method
US6383168B1 (en)	1998-12-08	2002-05-07	Bioject Medical Technologies Inc.	Needleless syringe with prefilled cartridge
US6132395A (en) *	1998-12-08	2000-10-17	Bioject, Inc.	Needleless syringe with prefilled cartridge
US6406455B1 (en) *	1998-12-18	2002-06-18	Biovalve Technologies, Inc.	Injection devices
DE19859137C1 (de) *	1998-12-21	2000-05-18	Ferton Holding Sa	Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
US6849060B1 (en)	1999-01-29	2005-02-01	Powderject Research Limited	Particle delivery device
US6328714B1 (en) *	1999-01-29	2001-12-11	Powderject Research Limited	Particle delivery device
US7060048B1 (en) *	1999-04-16	2006-06-13	Powerject Research Limited	Needleless syringe
AU4239300A (en)	1999-04-16	2000-11-02	Johnson & Johnson Consumer Companies, Inc.	Electrotransport delivery system comprising internal sensors
AU4656000A (en)	1999-04-22	2000-11-10	Gilbert Garitano	Needleless permanent makeup and tattoo device
US6689103B1 (en)	1999-05-07	2004-02-10	Scimed Life System, Inc.	Injection array apparatus and method
US6319230B1 (en)	1999-05-07	2001-11-20	Scimed Life Systems, Inc.	Lateral needle injection apparatus and method
US7192713B1 (en)	1999-05-18	2007-03-20	President And Fellows Of Harvard College	Stabilized compounds having secondary structure motifs
US7147633B2 (en) *	1999-06-02	2006-12-12	Boston Scientific Scimed, Inc.	Method and apparatus for treatment of atrial fibrillation
AU5595300A (en) *	1999-06-02	2000-12-18	Microheart, Inc.	Devices and methods for delivering a drug
AU6076200A (en)	1999-07-08	2001-01-30	Johnson & Johnson Consumer Companies, Inc.	Exothermic bandage
US6890553B1 (en)	1999-07-08	2005-05-10	Johnson & Johnson Consumer Companies, Inc.	Exothermic topical delivery device
WO2001013975A2 (en) *	1999-08-20	2001-03-01	Bioject, Inc.	Dna-based intramuscular injection system for humans
US6319224B1 (en) *	1999-08-20	2001-11-20	Bioject Medical Technologies Inc.	Intradermal injection system for injecting DNA-based injectables into humans
US20050027239A1 (en) *	1999-08-20	2005-02-03	Stout Richard R.	Intradermal injection system for injecting DNA-based injectables into humans
CN102766210B (zh)	1999-08-24	2015-07-08	E.R.施贵宝&圣斯有限责任公司	人ctla-4抗体及其应用
US7133717B2 (en) *	1999-08-25	2006-11-07	Johnson & Johnson Consumer Companies, Inc.	Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US7113821B1 (en)	1999-08-25	2006-09-26	Johnson & Johnson Consumer Companies, Inc.	Tissue electroperforation for enhanced drug delivery
US7074210B2 (en) *	1999-10-11	2006-07-11	Felton International, Inc.	Universal protector cap with auto-disable features for needle-free injectors
EP1220697B1 (de)	1999-10-11	2004-12-29	Felton International, Inc.	Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US6843781B2 (en) *	1999-10-14	2005-01-18	Becton, Dickinson And Company	Intradermal needle
US6494865B1 (en)	1999-10-14	2002-12-17	Becton Dickinson And Company	Intradermal delivery device including a needle assembly
US6776776B2 (en) *	1999-10-14	2004-08-17	Becton, Dickinson And Company	Prefillable intradermal delivery device
US6569143B2 (en)	1999-10-14	2003-05-27	Becton, Dickinson And Company	Method of intradermally injecting substances
US6569123B2 (en)	1999-10-14	2003-05-27	Becton, Dickinson And Company	Prefillable intradermal injector
US20020193740A1 (en)	1999-10-14	2002-12-19	Alchas Paul G.	Method of intradermally injecting substances
US7887506B1 (en)	1999-11-23	2011-02-15	Pulse Needlefree Systems, Inc.	Safety mechanism to prevent accidental patient injection and methods of same
CN1285389C (zh) *	1999-11-23	2006-11-22	无针风险投资公司	具有驱动装置和锁紧装置的注射器组件
US7029457B2 (en) *	1999-11-23	2006-04-18	Felton International, Inc.	Jet injector with hand piece
US6770054B1 (en)	1999-11-23	2004-08-03	Felton International, Inc.	Injector assembly with driving means and locking means
US6344027B1 (en)	1999-12-08	2002-02-05	Scimed Life Systems, Inc.	Needle-less injection apparatus and method
US6613026B1 (en) *	1999-12-08	2003-09-02	Scimed Life Systems, Inc.	Lateral needle-less injection apparatus and method
WO2001051109A1 (en) *	2000-01-07	2001-07-19	Biovalve Technologies, Inc.	Injection device
CN1254541C (zh)	2000-02-23	2006-05-03	史密丝克莱恩比彻姆生物有限公司	新化合物
FR2805749B1 (fr) *	2000-03-01	2002-05-17	Poudres & Explosifs Ste Nale	Seringue sans aiguille a deux niveaux de vitesse d'injection
US7137968B1 (en)	2000-03-13	2006-11-21	Nucryst Pharmaceuticals Corp.	Transcutaneous medical device dressings and method of use
WO2001070309A1 (en) *	2000-03-23	2001-09-27	Antares Pharma, Inc.	Single use disposable jet injector
US6719987B2 (en)	2000-04-17	2004-04-13	Nucryst Pharmaceuticals Corp.	Antimicrobial bioabsorbable materials
FR2807946B1 (fr)	2000-04-19	2002-06-07	Poudres & Explosifs Ste Nale	Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
US6716190B1 (en) *	2000-04-19	2004-04-06	Scimed Life Systems, Inc.	Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
US7404815B2 (en) *	2000-05-01	2008-07-29	Lifescan, Inc.	Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6689101B2 (en) *	2000-05-22	2004-02-10	Pharmacia Ab	Medical arrangement
US6406456B1 (en)	2000-06-08	2002-06-18	Avant Drug Delivery Systems, Inc.	Jet injector
US6645169B1 (en) *	2000-06-08	2003-11-11	Avant Drug Delivery Systems, Inc.	Air-in-tip jet injector
DE10029325A1 (de) *	2000-06-20	2002-01-03	Peter Lell	Nadellose Injektionsvorrichtung mit pyrotechnischem Antrieb
EP1319069B1 (de)	2000-06-28	2008-05-21	Corixa Corporation	Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
US20030206966A1 (en) *	2000-07-27	2003-11-06	Burrell Robert E.	Methods of inducing apoptosis and modulating metalloproteinases
US6989157B2 (en) *	2000-07-27	2006-01-24	Nucryst Pharmaceuticals Corp.	Dry powders of metal-containing compounds
US7427416B2 (en) *	2000-07-27	2008-09-23	Nucryst Pharmaceuticals Corp.	Methods of treating conditions using metal-containing materials
US7008647B2 (en)	2001-04-23	2006-03-07	Nucryst Pharmaceuticals Corp.	Treatment of acne
US7255881B2 (en) *	2000-07-27	2007-08-14	Nucryst Pharmaceuticals Corp.	Metal-containing materials
ATE282420T1 (de)	2000-07-27	2004-12-15	Nucryst Pharm Corp	Verwendung von edelmetallen zur herstellung eines arzneitmittels zur behandlung von hyperproliferativen hautstörungen und krankheiten
US7001617B2 (en)	2001-04-23	2006-02-21	Nueryst Pharmaceuticals Corp.	Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US20040191329A1 (en) *	2000-07-27	2004-09-30	Burrell Robert E.	Compositions and methods of metal-containing materials
US20030180379A1 (en) *	2000-07-27	2003-09-25	Burrell Robert E.	Solutions and aerosols of metal-containing compounds
US20030185901A1 (en)	2000-07-27	2003-10-02	Burrell Robert E.	Methods of treating conditions with a metal-containing material
US6939568B2 (en)	2001-04-23	2005-09-06	Nucryst Pharmaceuticals Corp.	Treatment of inflammatory skin conditions
GB0022742D0 (en)	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
CA2324045A1 (fr) *	2000-10-20	2002-04-20	Universite De Sherbrooke	Seringue sans aiguille pour l'injection sous-cutanee de poudres medicamenteuses
FR2815544B1 (fr)	2000-10-23	2003-02-14	Poudres & Explosifs Ste Nale	Seringue sans aiguille securisee a architecture compacte
US6652483B2 (en) *	2000-11-07	2003-11-25	Avant Drug Delivery Systems, Inc.	Needleless jet injector system with separate drug reservoir
US6626863B1 (en)	2000-11-22	2003-09-30	Nusaf, L.L.C.	Safety syringe
KR20030071780A (ko) *	2000-11-30	2003-09-06	바이오밸브 테크놀로지스, 인코포레이티드	주입기
GB0100756D0 (en)	2001-01-11	2001-02-21	Powderject Res Ltd	Needleless syringe
EP1351730B1 (de) *	2001-01-18	2006-06-28	Medrad, Inc.	Spritzenanschlussflächen und adaptern für verwendung mit medizinische injektoren
US6758837B2 (en)	2001-02-08	2004-07-06	Pharmacia Ab	Liquid delivery device and method of use thereof
DE60239594D1 (de)	2001-02-23	2011-05-12	Glaxosmithkline Biolog Sa	Influenza vakzinzusammensetzungen zur intradermaler verabreichung
US6645170B2 (en) *	2001-03-05	2003-11-11	Bioject Medical Technologies, Inc.	Simplified disposable needle-free injection apparatus and method
US6471669B2 (en)	2001-03-05	2002-10-29	Bioject Medical Technologies Inc.	Disposable needle-free injection apparatus and method
US20020172615A1 (en) *	2001-03-08	2002-11-21	Archie Woodworth	Apparatus for and method of manufacturing a prefilled sterile container
US20020139088A1 (en)	2001-03-08	2002-10-03	Archie Woodworth	Polymeric syringe body and stopper
EP1368104A1 (de)	2001-03-14	2003-12-10	PenJet Corporation	Vorrichtung und methode zum entfernen von in lösungen gelöstem gas
ZA200200808B (en)	2001-03-22	2002-08-12	Roche Diagnostics Gmbh	Needleless hypodermic injection system, application device and medication cartridge therefor.
US7795218B2 (en)	2001-04-12	2010-09-14	Bioaxone Therapeutique Inc.	ADP-ribosyl transferase fusion variant proteins
GB0109297D0 (en)	2001-04-12	2001-05-30	Glaxosmithkline Biolog Sa	Vaccine
US6613010B2 (en)	2001-04-13	2003-09-02	Penjet Corporation	Modular gas-pressured needle-less injector
US20050192530A1 (en) *	2001-04-13	2005-09-01	Penjet Corporation	Method and apparatus for needle-less injection with a degassed fluid
US6755220B2 (en)	2001-04-27	2004-06-29	Penjet Corporation	Method and apparatus for filling or refilling a needle-less injector
CA2446788A1 (en)	2001-05-09	2002-11-14	Corixa Corporation	Compositions and methods for the therapy and diagnosis of prostate cancer
TWI228420B (en)	2001-05-30	2005-03-01	Smithkline Beecham Pharma Gmbh	Novel vaccine composition
US20100221284A1 (en)	2001-05-30	2010-09-02	Saech-Sisches Serumwerk Dresden	Novel vaccine composition
US6648850B2 (en) *	2001-06-08	2003-11-18	Bioject, Inc.	Durable needle-less jet injector apparatus and method
JP2004531578A (ja) *	2001-06-29	2004-10-14	ベクトン・ディキンソン・アンド・カンパニー	ワクチンおよび遺伝子治療剤のマイクロカニューレによる皮内送達
US20060018877A1 (en) *	2001-06-29	2006-01-26	Mikszta John A	Intradermal delivery of vacccines and therapeutic agents
US7544188B2 (en) *	2001-07-19	2009-06-09	Intelliject, Inc.	Medical injector
US8440791B2 (en) *	2001-09-06	2013-05-14	Mgp Biotechnologies, Llc	Thimerosal removal device
US7767872B2 (en) *	2001-09-06	2010-08-03	Mpg Biotechnologies, Llc	Thimerosal removal device
US6669664B2 (en)	2001-09-07	2003-12-30	Avant Drug Delivery Systems, Inc.	Vacuum control cycle for jet injector
MXPA04002631A (es) *	2001-09-20	2004-07-08	Glaxo Group Ltd	Vacunas de adn optimizadas por codon gag-vih.
US6824526B2 (en)	2001-10-22	2004-11-30	Penjet Corporation	Engine and diffuser for use with a needle-less injector
GB0125506D0 (en)	2001-10-24	2001-12-12	Weston Medical Ltd	Needle free injection method and apparatus
CA2465502C (en) *	2001-11-09	2011-03-22	Pedro De La Serna	Pneumatic powered autoinjector
EP1443992B1 (de) *	2001-11-09	2007-01-03	Alza Corporation	Zusammenschiebbarer spritzenbehälter
US6607510B2 (en)	2001-11-09	2003-08-19	Bioject Medical Technologies Inc.	Disposable needle-free injection apparatus and method
TWI222370B (en) *	2001-12-14	2004-10-21	Roche Diagnostics Gmbh	Needleless hypodermic injection device
EP1581119B1 (de)	2001-12-17	2013-01-30	Corixa Corporation	Zusammensetzungen und verfahren zur behandlung und diagnose von entzündlicher darmerkrankung
JP2005518873A (ja) *	2002-03-04	2005-06-30	ナノパステクノロジーズリミテッド	生体障壁を横切る流体輸送の為の装置及び方法
US6912417B1 (en)	2002-04-05	2005-06-28	Ichor Medical Systmes, Inc.	Method and apparatus for delivery of therapeutic agents
AU2003221878A1 (en)	2002-04-12	2003-10-27	Schering Corporation	G-protein coupled receptor ligands and methods
BR122017016940B8 (pt)	2002-04-25	2021-07-27	Transkaryotic Therapies Inc	método para preparação de uma composição farmacêutica compreendendo alfa-galactosidase a
NZ536475A (en)	2002-05-24	2008-06-30	Schering Corp	Neutralizing human anti-igfr antibody
US7238167B2 (en) *	2002-06-04	2007-07-03	Bioject Inc.	Needle-free injection system
US6676630B2 (en)	2002-06-04	2004-01-13	Bioject Medical Technologies, Inc.	Needle-free injection system
US7156823B2 (en) *	2002-06-04	2007-01-02	Bioject Inc.	High workload needle-free injection system
US20040132058A1 (en)	2002-07-19	2004-07-08	Schering Corporation	NPC1L1 (NPC3) and methods of use thereof
US6883222B2 (en) *	2002-10-16	2005-04-26	Bioject Inc.	Drug cartridge assembly and method of manufacture
KR20110017020A (ko)	2002-10-17	2011-02-18	젠맵 에이/에스	Ｃｄ20에 대한 인간 모노클로날 항체
CA2500829A1 (en) *	2002-10-22	2004-05-06	Nucryst Pharmaceuticals Corp.	Prophylactic treatment methods
US7018356B2 (en)	2002-10-31	2006-03-28	Wise Roger R	Method and apparatus for adjusting the contents of a needle-less injector
DE10254601A1 (de)	2002-11-22	2004-06-03	Ganymed Pharmaceuticals Ag	Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
CN100464796C (zh) *	2002-11-25	2009-03-04	特克法马许可公司	包括可复位安全释放设备的自动注射器
US7960522B2 (en)	2003-01-06	2011-06-14	Corixa Corporation	Certain aminoalkyl glucosaminide phosphate compounds and their use
DK1589934T3 (en)	2003-01-06	2015-12-21	Corixa Corp	Certain AMINOAL COOLER GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND APPLICATION
JP2007524348A (ja)	2003-01-07	2007-08-30	ダイアックス、コープ	クニッツドメインライブラリー
PT2857036T (pt)	2003-01-31	2017-03-13	Mount Sinai School Of Medicine Of N Y Univ	Terapia combinada para o tratamento de distúrbios de deficiência proteica
US6935384B2 (en) *	2003-02-19	2005-08-30	Bioject Inc.	Needle-free injection system
FR2852517B1 (fr) *	2003-03-21	2005-11-11		Dispositif d'injection sans aiguille a cartouche pyrotechnique et procede d'assemblage d'un tel dispositif
US20060184101A1 (en) *	2003-04-21	2006-08-17	Ravi Srinivasan	Microjet devices and methods for drug delivery
AU2004232366A1 (en) *	2003-04-21	2004-11-04	Corium International, Inc.	Apparatus and methods for repetitive microjet drug delivery
EP1631590B1 (de)	2003-04-23	2011-07-27	Medarex, Inc.	Humanisierte antikörper gegen interferon-alpha-rezeptor-1 (ifnar-1)
CA2525017A1 (en) *	2003-05-09	2004-12-23	Anges Mg, Inc.	Needleless syringe having medical agent accommodated therein
ES2427641T3 (es)	2003-05-22	2013-10-31	Ibio, Inc.	Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana
AU2003270473A1 (en) *	2003-09-09	2005-04-27	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
IL157981A (en)	2003-09-17	2014-01-30	Elcam Medical Agricultural Cooperative Ass Ltd	Auto injector
GB0325836D0 (en) *	2003-11-05	2003-12-10	Celltech R&D Ltd	Biological products
SI1983000T1 (sl)	2003-11-21	2015-12-31	Ucb Biopharma Sprl	Postopek za zdravljenje multiple skleroze z zaviranjem aktivnosti il-17
US7563245B2 (en) *	2003-11-21	2009-07-21	Limin Mu	Syringe for powder medicament premixing
KR101374514B1 (ko)	2003-12-10	2014-03-13	메다렉스, 인코포레이티드	Ｉｐ―１０ 항체 및 그의 용도
ES2399050T3 (es)	2003-12-10	2013-03-25	Medarex, Inc.	Anticuerpos contra interferón alfa y sus usos
US20060147946A1 (en) *	2004-01-27	2006-07-06	Pinchas Akiva	Novel calcium channel variants and methods of use thereof
NZ585119A (en)	2004-03-08	2011-08-26	Ichor Medical Systems Inc	Medical injector with surrounding electrical field generating penetrating electrodes
IL160891A0 (en)	2004-03-16	2004-08-31		Auto-mix needle
DE102004024617A1 (de)	2004-05-18	2005-12-29	Ganymed Pharmaceuticals Ag	Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US20060024268A1 (en) *	2004-05-19	2006-02-02	Wyeth	Modulation of immunoglobulin production and atopic disorders
US7717874B2 (en) *	2004-05-28	2010-05-18	Bioject, Inc.	Needle-free injection system
KR20150041193A (ko)	2004-06-21	2015-04-15	메다렉스, 엘.엘.시.	인터페론 알파 수용체 1 항체 및 그의 용도
JP2008515774A (ja)	2004-08-03	2008-05-15	ダイアックスコーポレイション	ｈＫ１結合タンパク質
GB0417852D0 (en)	2004-08-11	2004-09-15	Biotica Tech Ltd	Production of polyketides and other natural products
US20060040895A1 (en) *	2004-08-19	2006-02-23	Kipling Thacker	Aesthetic use of hyaluronan
CA2478458A1 (en) *	2004-08-20	2006-02-20	Michael Panzara	Treatment of pediatric multiple sclerosis
EP2298340B1 (de)	2004-09-22	2014-04-16	GlaxoSmithKline Biologicals S.A.	Immunogene Zusammensetzung zur Verwendung zur Impfung gegen Staphylokokken
US9492400B2 (en) *	2004-11-04	2016-11-15	Massachusetts Institute Of Technology	Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US20060099144A1 (en)	2004-11-08	2006-05-11	Schering Corporation	Tumor association of MDL-1 and methods
CA2629751A1 (en)	2004-11-12	2006-05-18	The University Of British Columbia	Antimicrobial peptides
JP2008520717A (ja)	2004-11-19	2008-06-19	バイオジェン・アイデック・エムエイ・インコーポレイテッド	多発性硬化症についての処置
US11590286B2 (en)	2004-11-22	2023-02-28	Kaleo, Inc.	Devices, systems and methods for medicament delivery
US7947017B2 (en) *	2004-11-22	2011-05-24	Intelliject, Inc.	Devices, systems and methods for medicament delivery
AU2004325202B2 (en) *	2004-11-22	2009-02-19	Kaleo, Inc.	Devices, systems, and methods for medicament delivery
US10737028B2 (en)	2004-11-22	2020-08-11	Kaleo, Inc.	Devices, systems and methods for medicament delivery
US7648482B2 (en)	2004-11-22	2010-01-19	Intelliject, Inc.	Devices, systems, and methods for medicament delivery
US7648483B2 (en)	2004-11-22	2010-01-19	Intelliject, Inc.	Devices, systems and methods for medicament delivery
EP1819383A4 (de) *	2004-12-01	2010-08-18	Acushot Inc	Nadelloses injektionsgerät
DE602005025685D1 (de)	2004-12-03	2011-02-10	Schering Corp	Biologische marker zur vorauswahl von patienten für die anti-igf1r-therapie
US20090169477A1 (en) *	2004-12-03	2009-07-02	Michael Panzara	Delaying or preventing onset of multiple sclerosis
US7351226B1 (en) *	2004-12-07	2008-04-01	Glenn Herskowitz	Medical infusion pump
EP1841866B1 (de) *	2005-01-25	2009-04-22	Sky Genetics, Inc.	Nukleinsäuren für die apoptose von krebszellen
US20060183893A1 (en) *	2005-01-25	2006-08-17	North Don A	Nucleic acids for apoptosis of cancer cells
US8231573B2 (en) *	2005-02-01	2012-07-31	Intelliject, Inc.	Medicament delivery device having an electronic circuit system
DK2058020T3 (da)	2005-02-01	2013-01-07	Intelliject Inc	Indretning til indgivelse af lægemiddel
US7731686B2 (en)	2005-02-01	2010-06-08	Intelliject, Inc.	Devices, systems and methods for medicament delivery
US8361026B2 (en)	2005-02-01	2013-01-29	Intelliject, Inc.	Apparatus and methods for self-administration of vaccines and other medicaments
US8206360B2 (en)	2005-02-01	2012-06-26	Intelliject, Inc.	Devices, systems and methods for medicament delivery
US9022980B2 (en) *	2005-02-01	2015-05-05	Kaleo, Inc.	Medical injector simulation device
US20090124993A1 (en)	2005-02-17	2009-05-14	Burkly Linda C	Treating neurological disorders
EP1848745B1 (de)	2005-02-18	2014-07-09	Medarex, L.L.C.	Fukose-freie monoklonale anti-cd30 antikörper
US20100061994A1 (en) *	2005-03-11	2010-03-11	Rose Mary Sheridan	Medical uses of 39-desmethoxyrapamycin and analogues thereof
GB0504994D0 (en)	2005-03-11	2005-04-20	Biotica Tech Ltd	Novel compounds
PE20061428A1 (es)	2005-03-23	2007-01-16	Glaxosmithkline Biolog Sa	Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
EP3312196B1 (de)	2005-03-23	2019-07-17	Genmab A/S	Antikörper gegen cd38 zur behandlung von multiplem myelom
ES2440953T3 (es)	2005-03-31	2014-01-31	The General Hospital Corporation	Modulación de la actividad de HGF/HGFR para tratar un linfedema
ES2732625T3 (es)	2005-04-04	2019-11-25	Univ Florida	Análogos de poliéter de desferritiocina
PL2161336T5 (pl)	2005-05-09	2017-10-31	Ono Pharmaceutical Co	Ludzkie przeciwciała monoklonalne przeciwko białku Programmed Death 1 (PD-1) oraz sposoby leczenia raka z zastosowaniem samych przeciwciał anty-PD-1 lub w połączeniu z innymi środkami immunoterapeutycznymi
AU2006247065B8 (en)	2005-05-17	2012-07-12	Amicus Therapeutics, Inc.	A method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives
NZ564092A (en)	2005-05-27	2010-05-28	Biogen Idec Inc	TWEAK binding antibodies
US20060271014A1 (en) *	2005-05-31	2006-11-30	Mallinckrodt Inc.	Heat retention device for a syringe and methods of use
US20070118093A1 (en) *	2005-06-20	2007-05-24	Von Muhlen Marcio G	High-speed jet devices for drug delivery
CA2612241C (en)	2005-07-01	2018-11-06	Medarex, Inc.	Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
US20100119525A1 (en) *	2005-08-01	2010-05-13	Mount Sinai Schoool Of Medicine Of New York University	Method for extending longevity using npc1l1 antagonists
CN101378781B (zh) *	2005-08-03	2013-08-07	美国弗劳恩霍夫股份有限公司	制造免疫球蛋白的组合物和方法
US20070055199A1 (en) *	2005-08-10	2007-03-08	Gilbert Scott J	Drug delivery device for buccal and aural applications and other areas of the body difficult to access
EP1762575A1 (de)	2005-09-12	2007-03-14	Ganymed Pharmaceuticals AG	Identifizierung Tumor-assoziierter Antigene für Diagnoseund Therapie
NZ566395A (en)	2005-09-26	2012-03-30	Medarex Inc	Human monoclonal antibodies to CD70
US7910708B2 (en)	2005-10-21	2011-03-22	Novartis Ag	Anti-IL13 human antibodies
US20070099246A1 (en) *	2005-11-03	2007-05-03	Sandy John D	Antibodies, assays and kits to quantitate cartilage destruction
WO2007061896A1 (en)	2005-11-17	2007-05-31	Zogenix, Inc.	Delivery of viscous formulations by needle-free injection
EP1790664A1 (de)	2005-11-24	2007-05-30	Ganymed Pharmaceuticals AG	Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US7695449B2 (en) *	2005-12-05	2010-04-13	Xinming Wang	Automatic syringe
EP1960434B1 (de)	2005-12-08	2012-07-11	Medarex, Inc.	Humane monoklonale antikörper gegen fucosyl-gm1 und verfahren zur anwendung von anti-fucosyl-gm1
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
WO2007070682A2 (en) *	2005-12-15	2007-06-21	Massachusetts Institute Of Technology	System for screening particles
GB0607088D0 (en)	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
BRPI0620460B8 (pt)	2005-12-22	2021-05-25	Glaxosmithkline Biologicals Sa	uso de composição imunogênica para bebês, e, processo para produzir uma vacina
US20090081157A1 (en)	2006-01-09	2009-03-26	Richard Syd Kornbluth	Immunostimulatory Combinations for Vaccine Adjuvants
US20070166774A1 (en) *	2006-01-17	2007-07-19	Groman Ernest V	Functional immunoassay
RS52459B (sr)	2006-02-07	2013-02-28	Shire Human Genetic Therapies Inc.	Stabilizovane kompozicije glukocerebrozidaze
MX2008010341A (es) *	2006-02-09	2008-11-18	Deka Products Lp	Sistemas y metodos adhesivos y perifericos para dispositivos medicos.
WO2008048344A2 (en) *	2006-02-13	2008-04-24	Fraunhofer Usa, Inc.	Bacillus anthracis antigens, vaccine compositions, and related methods
AU2007215082B2 (en) *	2006-02-13	2012-07-12	Ibio, Inc.	HPV antigens, vaccine compositions, and related methods
EP1984405A4 (de) *	2006-02-13	2010-06-30	Fraunhofer Usa Inc	Influenza-antigene, impfstoffzusammensetzungen und zugehörige verfahren
US7922701B2 (en) *	2006-02-17	2011-04-12	Buchman Alan L	Catheter cleaning devices
CA2644694C (en) *	2006-03-10	2014-05-13	Sangeeta N. Bhatia	Triggered self-assembly conjugates and nanosystems
US7666912B2 (en)	2006-03-23	2010-02-23	Massachusetts Eye And Ear Infirmary	Compositions and methods for reducing body fat
US20080045471A1 (en) *	2006-03-27	2008-02-21	North Don A	Nucleic Acids For Apoptosis Of Cancer Cells
MY148405A (en)	2006-03-30	2013-04-30	Glaxosmithkline Biolog Sa	Immunogenic composition
CA2648099C (en) *	2006-03-31	2012-05-29	The Brigham And Women's Hospital, Inc	System for targeted delivery of therapeutic agents
WO2007120638A2 (en) *	2006-04-12	2007-10-25	President And Fellows Of Harvard College	Methods and compositions for modulating glycosylation
JP2009534390A (ja) *	2006-04-21	2009-09-24	アムジェンインコーポレイテッド	生物医薬品製剤のための緩衝剤
US20070258941A1 (en) *	2006-05-02	2007-11-08	Pfister Brian E	Methods and compositions for remediation of disc herniation by modifying structure
EP2019691B1 (de)	2006-05-15	2020-08-12	Massachusetts Institute of Technology	Polymere für funktionelle partikel
WO2007137117A2 (en) *	2006-05-17	2007-11-29	Massachusetts Institute Of Technology	Aptamer-directed drug delivery
BRPI0712607A8 (pt)	2006-05-25	2019-06-04	Biogen Idec Inc	métodos de tratamento de acidente vascular cerebral
US9150626B2 (en) *	2006-06-02	2015-10-06	President And Fellows Of Harvard College	Protein surface remodeling
US9381477B2 (en)	2006-06-23	2016-07-05	Massachusetts Institute Of Technology	Microfluidic synthesis of organic nanoparticles
US20080112888A1 (en)	2006-06-30	2008-05-15	Schering Corporation	Igfbp2 biomarker
EP2046383B1 (de)	2006-07-04	2014-11-19	Genmab A/S	Cd20-bindungsmoleküle zur behandlung von copd
CN105727276A (zh)	2006-07-17	2016-07-06	葛兰素史密丝克莱恩生物有限公司	流感疫苗
US20080033347A1 (en) *	2006-08-03	2008-02-07	Becton, Dickinson And Company	Detachable needle syringe having reduced dead space
US7618396B2 (en) *	2006-08-09	2009-11-17	Avant Medical Corp.	Injection system with hidden needles
EP2046834B9 (de)	2006-08-11	2013-04-10	Ono Pharmaceutical Co., Ltd.	Monoklonale antikörper gegen stromal derived factor-1 (sdf-1-)
US9115358B2 (en) *	2006-08-11	2015-08-25	President And Fellows Of Harvard College	Moenomycin biosynthesis-related compositions and methods of use thereof
US20090269342A1 (en) *	2006-08-14	2009-10-29	Massachusetts Institute Of Technology	Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
AU2007332987B2 (en) *	2006-08-14	2013-01-10	Massachusetts Institute Of Technology	Hemagglutinin polypeptides, and reagents and methods relating thereto
KR20090088852A (ko)	2006-09-05	2009-08-20	메다렉스, 인코포레이티드	골형성 단백질의 항체와 이의 수용체 및 이의 사용방법
US7942845B2 (en) *	2006-09-19	2011-05-17	Bioject, Inc.	Needle-free injector and process for providing serial injections
ES2625798T3 (es)	2006-10-02	2017-07-20	E. R. Squibb & Sons, L.L.C.	Anticuerpos humanos que se unen a CXCR4 y usos de los mismos
EP2081553B1 (de) *	2006-10-06	2020-08-12	Amgen Inc.	Stabile antikörper-formulierungen
US7547293B2 (en)	2006-10-06	2009-06-16	Bioject, Inc.	Triggering mechanism for needle-free injector
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
ES2397714T3 (es)	2006-10-12	2013-03-08	Glaxosmithkline Biologicals S.A.	Vacuna que comprende un adyuvante de emulsión de aceite en agua
EP2433648A3 (de)	2006-10-12	2012-04-04	GlaxoSmithKline Biologicals S.A.	Impfstoff mit einem Öl-in-wasser-emulsionshilfsstoff
DK2068922T3 (da)	2006-10-19	2012-10-08	Csl Ltd	Anti-IL-13Ralfa1-antistoffer samt deres anvendelser
JP5623743B2 (ja) *	2006-10-20	2014-11-12	アムジエン・インコーポレーテツド	安定なポリペプチド製剤
SG178002A1 (en)	2006-10-20	2012-02-28	Biogen Idec Inc	Treatment of demyelinating disorders
US8618248B2 (en)	2006-10-31	2013-12-31	President And Fellows Of Harvard College	Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides
US20090124996A1 (en) *	2006-11-03	2009-05-14	Scott Heneveld	Apparatus and methods for injecting high viscosity dermal fillers
AU2007334264A1 (en)	2006-11-15	2008-06-26	Medarex, Inc.	Human monoclonal antibodies to BTLA and methods of use
US20100303723A1 (en) *	2006-11-20	2010-12-02	Massachusetts Institute Of Technology	Drug delivery systems using fc fragments
WO2008070538A2 (en)	2006-12-01	2008-06-12	Anterios, Inc.	Micellar nanoparticles comprising botulinum toxin
EP2097097B1 (de)	2006-12-01	2018-05-30	E. R. Squibb & Sons, L.L.C.	Antikörper, insbesondere menschliche antikörper, die an cd22 binden und deren verwendung
WO2008073856A2 (en) *	2006-12-08	2008-06-19	Massachusetts Institute Of Technology	Delivery of nanoparticles and/or agents to cells
CL2007003622A1 (es)	2006-12-13	2009-08-07	Medarex Inc	Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
AU2007333098A1 (en)	2006-12-14	2008-06-19	Medarex, Inc.	Human antibodies that bind CD70 and uses thereof
MX2009006594A (es) *	2006-12-21	2009-08-12	Amgen Inc	Formulaciones de ph regulado y estables que contienen polipeptidos.
EP2474523B1 (de)	2006-12-26	2020-04-08	Lantheus Medical Imaging, Inc.	Liganden zur Bildgebung der kardialen Innervation
WO2008083209A2 (en) *	2006-12-29	2008-07-10	Amir Genosar	Hypodermic drug delivery reservoir and apparatus
EP2125075A2 (de)	2007-01-22	2009-12-02	Intelliject, Inc.	Medizinischer injektor mit konformitätsverfolgung und -überwachung
PL2118123T3 (pl)	2007-01-31	2016-06-30	Dana Farber Cancer Inst Inc	Stabilizowane peptydy p53 i ich zastosowania
EP2134830A2 (de) *	2007-02-09	2009-12-23	Massachusetts Institute of Technology	Oszillations-zellkultur-bioreaktor
SG178789A1 (en)	2007-02-16	2012-03-29	Merrimack Pharmaceuticals Inc	Antibodies against erbb3 and uses thereof
US7744563B2 (en) *	2007-02-23	2010-06-29	Bioject, Inc.	Needle-free injection devices and drug delivery systems therefor
EP1970384A1 (de)	2007-03-14	2008-09-17	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
CN104003955A (zh)	2007-03-15	2014-08-27	佛罗里达大学研究基金公司	去铁硫辛聚醚类似物
US7960139B2 (en)	2007-03-23	2011-06-14	Academia Sinica	Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
BRPI0809435A2 (pt)	2007-03-27	2014-09-09	Sea Lane Biotechnologies, Llc	Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos
JP5631201B2 (ja)	2007-03-28	2014-11-26	プレジデントアンドフェローズオブハーバードカレッジ	ステッチングされたポリペプチド
WO2008124634A1 (en)	2007-04-04	2008-10-16	Massachusetts Institute Of Technology	Polymer-encapsulated reverse micelles
WO2008124632A1 (en)	2007-04-04	2008-10-16	Massachusetts Institute Of Technology	Amphiphilic compound assisted nanoparticles for targeted delivery
US8778348B2 (en) *	2007-04-28	2014-07-15	Ibio Inc.	Trypanosoma antigens, vaccine compositions, and related methods
GB0708758D0 (en)	2007-05-04	2007-06-13	Powderject Res Ltd	Particle cassettes and process thereof
CA2688346A1 (en)	2007-05-23	2008-12-04	Vical Incorporated	Compositions and methods for enhancing immune responses to vaccines
EP1997832A1 (de)	2007-05-29	2008-12-03	Ganymed Pharmaceuticals AG	Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
AU2008262384B9 (en)	2007-06-05	2014-11-27	Yale University	Inhibitors of receptor tyrosine kinases and methods of use thereof
NZ595526A (en) *	2007-06-14	2013-03-28	Biogen Idec Inc	Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
MX2009013118A (es) *	2007-06-14	2010-03-04	Crucell Switzerland Ag	Vacuna intradermica contra la influenza.
US8524444B2 (en)	2007-06-15	2013-09-03	President And Fellows Of Harvard College	Methods and compositions for detections and modulating O-glycosylation
BRPI0813644B8 (pt)	2007-06-26	2021-05-25	Glaxosmithkline Biologicals Sa	composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
US8404252B2 (en)	2007-07-11	2013-03-26	Fraunhofer Usa, Inc.	Yersinia pestis antigens, vaccine compositions, and related methods
DE102007034871A1 (de) *	2007-07-24	2009-01-29	Lts Lohmann Therapie-Systeme Ag	Einweginjektor mit handbetätigbarem Kolben
WO2009097006A2 (en)	2007-08-10	2009-08-06	Medarex, Inc.	Hco32 and hco27 and related examples
CA2696764A1 (en) *	2007-08-20	2009-02-26	Fraunhofer Usa, Inc.	Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
EP2190469B1 (de)	2007-09-04	2015-02-25	Compugen Ltd.	Polypeptide und polynukleotide und ihre verwendung als zielmolekül zur herstellung von arzneimitteln und biologika
GB0717337D0 (en)	2007-09-06	2007-10-17	Ucb Pharma Sa	Method of treatment
EP2205074A4 (de) *	2007-10-04	2013-07-31	Harvard College	Moenomycin-analoga, syntheseverfahren und verwendung
TWI489993B (zh)	2007-10-12	2015-07-01	Novartis Ag	骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
CA2917512C (en)	2007-10-12	2025-08-05	President And Fellows Of Harvard College	VACCINE NANOTECHNOLOGY
US9593340B2 (en) *	2007-10-15	2017-03-14	Admedus Vaccines Pty Ltd.	Expression system for modulating an immune response
CN101951954A (zh)	2007-11-02	2011-01-19	诺瓦提斯公司	调节低密度脂蛋白受体相关蛋白6(lrp6)的分子和方法
KR101811965B1 (ko)	2007-11-07	2017-12-22	셀덱스 쎄라퓨틱스, 인크.	인간 수지상 및 상피 세포 205(ｄｅｃ-205)에 결합하는 항체
US20090137949A1 (en) *	2007-11-26	2009-05-28	Bioject Inc.	Needle-free injection device with nozzle auto-disable
US8617099B2 (en) *	2007-11-26	2013-12-31	Bioject Inc.	Injection device plunger auto-disable
WO2009077993A2 (en)	2007-12-17	2009-06-25	Pfizer Limited	Treatment of interstitial cystitis
EP2231258A1 (de)	2007-12-21	2010-09-29	Aesthetic Sciences Corporation	Unabhängige druckinjektionsvorrichtung
JP2011508634A (ja)	2007-12-28	2011-03-17	アクティヴパック，インコーポレイテッド	患者への治療剤の投与に適したディスペンサおよび治療用パッケージ
DE102008011873A1 (de)	2007-12-30	2009-07-09	Idelevich, Evgeny	Applikationsvorrichtung und -verfahren zur automatisierten Medikamentenabgabe bei arteriellem Hypertonus
CN101951927A (zh) *	2008-01-03	2011-01-19	麻省理工学院	诱饵流感疗法
US8193182B2 (en)	2008-01-04	2012-06-05	Intellikine, Inc.	Substituted isoquinolin-1(2H)-ones, and methods of use thereof
KR101588309B1 (ko)	2008-01-22	2016-01-25	푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬	펩티드, 조성물 및 그의 용도
AU2009212442C1 (en)	2008-02-05	2014-07-17	Bristol-Myers Squibb Company	Alpha 5 - beta 1 antibodies and their uses
CN101952454B (zh)	2008-02-08	2014-06-04	米迪缪尼有限公司	具有减弱的Fc配体亲和性的抗IFNAR1抗体
AU2009233711B2 (en) *	2008-04-09	2015-02-12	Infinity Pharmaceuticals, Inc	Inhibitors of fatty acid amide hydrolase
US20120164178A1 (en)	2008-04-16	2012-06-28	Ballou Jr William Ripley	Vaccine
JP2011523353A (ja) *	2008-04-28	2011-08-11	プレジデントアンドフェロウズオブハーバードカレッジ	細胞透過のための過剰に荷電されたタンパク質
WO2009134336A1 (en) *	2008-04-28	2009-11-05	Zogenix, Inc.	Novel formulations for treatment of migraine
US9296810B2 (en)	2008-05-02	2016-03-29	Novartis Ag	Fibronectin-based binding molecules and uses thereof
USD994111S1 (en)	2008-05-12	2023-08-01	Kaleo, Inc.	Medicament delivery device cover
US8021344B2 (en)	2008-07-28	2011-09-20	Intelliject, Inc.	Medicament delivery device configured to produce an audible output
EP3403681A1 (de)	2008-05-30	2018-11-21	Allergan, Inc.	Injektionsvorrichtung für weichgewebsaufbauende füllstoffe, bioaktive mittel und andere biokompatible materialien in flüssiger oder gelform
BRPI0912043A2 (pt) *	2008-05-30	2019-09-24	Dana-Farber Cancer Institute, Inc.	métodos de tratamento de doença associada à cinesina meiótica
WO2009150623A1 (en)	2008-06-13	2009-12-17	Pfizer Inc	Treatment of chronic prostatitis
KR20170116193A (ko)	2008-06-20	2017-10-18	노파르티스 아게	응집이 감소된 면역글로불린
KR102080429B1 (ko)	2008-06-26	2020-02-21	안테리오스, 인코퍼레이티드	경피 운반
JP5986745B2 (ja)	2008-07-15	2016-09-06	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US20110144306A1 (en) *	2008-07-23	2011-06-16	President And Fellows Of Harvard College	Ligation of stapled polypeptides
KR20110033304A (ko) *	2008-07-23	2011-03-30	메사추세츠 인스티튜트 오브 테크놀로지	Ｄｎａ 손상에 대해 보호하고 신경세포 생존을 증가시키는 히스톤 디아세틸라제 1 (ｈｄａｃ1)의 활성화
WO2010011944A2 (en)	2008-07-25	2010-01-28	Wagner Richard W	Protein screeing methods
AR072999A1 (es)	2008-08-11	2010-10-06	Medarex Inc	Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
EP2166021A1 (de) *	2008-09-16	2010-03-24	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
US9901681B2 (en) *	2008-09-18	2018-02-27	Becton, Dickinson And Company	Medical injector with slidable sleeve activation
PL2342226T3 (pl)	2008-09-26	2017-01-31	Dana-Farber Cancer Institute, Inc.	Ludzkie przeciwciała anty-PD-1, PD-L1 i PD-L2 oraz ich zastosowania
US8734803B2 (en)	2008-09-28	2014-05-27	Ibio Inc.	Humanized neuraminidase antibody and methods of use thereof
US8343497B2 (en) *	2008-10-12	2013-01-01	The Brigham And Women's Hospital, Inc.	Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en)	2008-10-12	2013-11-26	The Brigham And Women's Hospital, Inc.	Nicotine immunonanotherapeutics
US8343498B2 (en)	2008-10-12	2013-01-01	Massachusetts Institute Of Technology	Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) *	2008-10-12	2012-10-02	Massachusetts Institute Of Technology	Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
KR101593285B1 (ko)	2008-10-29	2016-02-11	아블린쓰 엔.브이.	단일 도메인 항원 결합 분자의 제형
EP2376089B1 (de)	2008-11-17	2018-03-14	The Regents of the University of Michigan	Krebsvakzine-zusammensetzungen und anwendungsverfahren dafür
US9545483B2 (en) *	2008-12-02	2017-01-17	Sanofi-Aventis Deutschland Gmbh	Drive assembly suitable for use in a medication delivery device and medication delivery device
SI3187219T1 (sl) *	2008-12-02	2020-09-30	Allergan, Inc.	Injekcijska naprava
EP2865689A1 (de)	2008-12-08	2015-04-29	Compugen Ltd.	FAM26F Polypeptide und Polynukleotide und Verwendungen davon als Arzneimittel-Target zur Herstellung von Arzneimitteln und Biologika
WO2010067345A1 (en) *	2008-12-08	2010-06-17	Perf-Action Technologies Ltd.	Erosion prevention for o-rings in a high pressure injection device
WO2010077806A1 (en)	2008-12-15	2010-07-08	Greenlight Biosciences, Inc.	Methods for control of flux in metabolic pathways
EP3805758A1 (de)	2008-12-19	2021-04-14	Medirista Biotechnologies AB	Oxidiertes cardiolipin als neuer proinflammatorischer faktor
CN105132387A (zh) *	2008-12-22	2015-12-09	绿光生物科学公司	用于制造化合物的组合物和方法
PT2403878T (pt)	2009-03-05	2017-09-01	Squibb & Sons Llc	Anticorpos completamente humanos específicos a cadm1
GB0904540D0 (en)	2009-03-17	2009-04-29	Biotica Tech Ltd	Novel compounds and methods for their production
EP2416660B1 (de)	2009-04-07	2014-07-02	Infinity Pharmaceuticals, Inc.	Fettsäureamidhydrolase-hemmer
WO2010118159A1 (en)	2009-04-07	2010-10-14	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
BRPI1010517A2 (pt)	2009-04-09	2017-01-31	Amicus Therapeutics Inc	métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
WO2010121141A1 (en) *	2009-04-17	2010-10-21	Biogen Idec Ma Inc.	Compositions and methods to treat acute myelogenous leukemia
EP3009454A3 (de)	2009-04-20	2016-10-19	Oxford Bio Therapeutics Limited	Antikörper spezifisch gegen cadherin-17
EP2243505B1 (de) *	2009-04-23	2018-02-14	Bayer Healthcare LLC	Spritzenbaugruppen, Verfahren zum Bilden von Spritzenbaugruppen
CA2993053A1 (en)	2009-04-27	2010-11-04	Novartis Ag	Antagonistic activin receptor iib (actriib) antibodies for increasing muscle growth
US8715657B2 (en)	2009-04-27	2014-05-06	Novartis Ag	Therapeutic antibodies binding IL12Rβ1
US9221886B2 (en)	2009-04-28	2015-12-29	President And Fellows Of Harvard College	Supercharged proteins for cell penetration
KR20120088550A (ko)	2009-05-04	2012-08-08	애보트 리서치 비.브이.	증진된 생체내 안정성을 갖는 신경 성장 인자(ｎｇｆ)에 대한 항체
JP2012526839A (ja)	2009-05-13	2012-11-01	シーレーンバイオテクノロジーズ，エルエルシー	インフルエンザウイルスに対する中和分子
US8927551B2 (en) *	2009-05-18	2015-01-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) *	2009-05-18	2014-07-01	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) *	2009-05-18	2015-10-06	Infinity Pharmaceuticals, Inc.	Isoxazolines as inhibitors of fatty acid amide hydrolase
WO2010141074A2 (en)	2009-06-01	2010-12-09	President And Fellows Of Harvard College	O-glcnac transferase inhibitors and uses thereof
US8974423B2 (en) *	2009-06-01	2015-03-10	Sanofi-Aventis Deutschland Gmbh	Resettable drug delivery device
CA2769999C (en)	2009-06-01	2020-02-18	Shriners Hospitals For Children	A cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
PT2437785E (pt)	2009-06-04	2015-04-20	Novartis Ag	Método de identificação de sítios para conjugação de igg
WO2010146511A1 (en)	2009-06-17	2010-12-23	Pfizer Limited	Treatment of overactive bladder
BR112012000867A2 (pt)	2009-07-13	2019-09-24	Harvard College	"polipeptídeos bifuncional costurado e uso do mesmo"
IN2012DN00863A (de)	2009-07-31	2015-07-10	Medarex Inc
US8394922B2 (en)	2009-08-03	2013-03-12	Medarex, Inc.	Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
GB0913681D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
GB0914589D0 (en)	2009-08-20	2009-09-30	Biotica Tech Ltd	Novel compounds and methods for their production
WO2011029823A1 (en)	2009-09-09	2011-03-17	Novartis Ag	Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
JP2013505300A (ja)	2009-09-22	2013-02-14	エルロン・セラピューティクス・インコーポレイテッド	ペプチド模倣大環状分子
GB0916630D0 (en)	2009-09-22	2009-11-04	Secr Defence	Antibody
EP2483307A1 (de)	2009-09-29	2012-08-08	Fraunhofer USA, Inc.	Influenza-hämagglutinin-antikörper, zusammensetzungen daraus und zugehörige verfahren
GB0917816D0 (en)	2009-10-12	2009-11-25	Biotica Tech Ltd	Novel compounds and methods for their production
GB0917817D0 (en)	2009-10-12	2009-11-25	Biotica Tech Ltd	Novel compounds and methods for their production
EP2470569A1 (de)	2009-10-13	2012-07-04	Oxford Biotherapeutics Ltd.	Antikörper gegen epha10
WO2011047180A1 (en)	2009-10-14	2011-04-21	Merrimack Pharmaceuticals, Inc.	Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
DK2490532T3 (en)	2009-10-19	2017-02-27	Amicus Therapeutics Inc	Hitherto UNKNOWN COMPOSITIONS FOR PREVENTION AND / OR TREATMENT OF DEGENERATIVE DISORDERS IN THE CENTRAL Nervous System
PT2995306T (pt)	2009-10-19	2019-03-29	Amicus Therapeutics Inc	Novas composições para prevenção e/ou tratamento de disfunções de armazenamento lisossomal
WO2011051327A2 (en)	2009-10-30	2011-05-05	Novartis Ag	Small antibody-like single chain proteins
WO2011051466A1 (en)	2009-11-02	2011-05-05	Novartis Ag	Anti-idiotypic fibronectin-based binding molecules and uses thereof
US20120282276A1 (en)	2009-11-05	2012-11-08	The Regents Of The University Of Michigan	Biomarkers predictive of progression of fibrosis
US9428586B2 (en)	2009-12-01	2016-08-30	Compugen Ltd	Heparanase splice variant
US10087236B2 (en)	2009-12-02	2018-10-02	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US11377485B2 (en)	2009-12-02	2022-07-05	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US20110137260A1 (en)	2009-12-07	2011-06-09	Allergan, Inc.	Slotted syringe
KR101605932B1 (ko)	2009-12-18	2016-03-24	노파르티스 아게	Ｈｓｆ1-관련 질환을 치료하기 위한 유기 조성물
JP2013514795A (ja)	2009-12-22	2013-05-02	ノバルティスアーゲー	治療における使用のための四価ｃｄ４７抗体定常領域融合タンパク質
EP2937345B1 (de)	2009-12-29	2018-03-21	Dana-Farber Cancer Institute, Inc.	Typ-ii-raf-kinase-hemmer
US8637456B2 (en)	2010-01-27	2014-01-28	Massachusetts Institute Of Technology	Engineered polypeptide agents for targeted broad spectrum influenza neutralization
WO2011092233A1 (en)	2010-01-29	2011-08-04	Novartis Ag	Yeast mating to produce high-affinity combinations of fibronectin-based binders
EP2531511A1 (de) *	2010-02-03	2012-12-12	Infinity Pharmaceuticals, Inc.	Fettsäureamidhydrolase-hemmer
AU2011214465A1 (en)	2010-02-10	2012-08-30	Novartis Ag	Methods and compounds for muscle growth
CN102844023B (zh)	2010-03-08	2016-01-20	索隆-基特林癌症研究协会	Cdc7激酶抑制剂以及其用途
GB201003920D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Method of treatment
GB201003922D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Conjugation process
EP2547365A1 (de)	2010-03-17	2013-01-23	Abbott Research B.V.	Anti-ngf-antikörperzusammensetzungen
US9102697B2 (en)	2010-03-22	2015-08-11	President And Fellows Of Harvard College	Trioxacarcins and uses thereof
EP2371864A1 (de)	2010-03-23	2011-10-05	Ganymed Pharmaceuticals AG	Monoklonale Antikörper zur Krebsbehandlung
US20150231215A1 (en)	2012-06-22	2015-08-20	Randolph J. Noelle	VISTA Antagonist and Methods of Use
US10745467B2 (en)	2010-03-26	2020-08-18	The Trustees Of Dartmouth College	VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
MX342017B (es)	2010-03-26	2016-09-09	Dartmouth College	Proteina mediadora de celula t regulatoria vista, agentes de enlace de vista y uso de los mismos.
WO2011130332A1 (en)	2010-04-12	2011-10-20	Academia Sinica	Glycan arrays for high throughput screening of viruses
NZ602892A (en)	2010-04-13	2014-08-29	Celldex Therapeutics Inc	Antibodies that bind human cd27 and uses thereof
EA201291065A1 (ru)	2010-04-16	2013-03-29	Байоджен Айдек Ма Инк.	Антитела против vla-4
US9795658B2 (en)	2010-04-20	2017-10-24	Admedus Vaccines Pty Ltd	Expression system for modulating an immune response
CN107929306B (zh)	2010-04-23	2022-11-15	箭头制药公司	治疗β-ENaC-相关疾病的有机组合物
WO2011140151A1 (en)	2010-05-04	2011-11-10	Dyax Corp.	Antibodies against epidermal growth factor receptor (egfr)
CA2798273A1 (en)	2010-05-04	2011-11-10	Merrimack Pharmaceuticals, Inc.	Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US8450350B2 (en)	2010-05-05	2013-05-28	Infinity Pharmaceuticals, Inc.	Triazoles as inhibitors of fatty acid synthase
WO2011140190A1 (en)	2010-05-05	2011-11-10	Infinity Pharmaceuticals	Tetrazolones as inhibitors of fatty acid synthase
US8956833B2 (en)	2010-05-07	2015-02-17	Greenlight Biosciences, Inc.	Methods for control of flux in metabolic pathways through enzyme relocation
MX343721B (es)	2010-05-11	2016-11-17	Lantheus Medical Imaging Inc	Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
AU2011255534A1 (en)	2010-05-19	2012-12-20	Allergan, Inc.	Modular injection device
ES2664872T3 (es)	2010-06-18	2018-04-23	Taiho Pharmaceutical Co., Ltd	Moduladores PRPK-TPRKB y sus usos
CA2805024A1 (en)	2010-06-30	2012-01-05	Compugen Ltd.	Polypeptides and uses thereof as a drug for treatment of multiples sclerosis, rheumatoid arthritis and other autoimmune disorders
CA2804154C (en)	2010-07-01	2021-06-01	The Texas A&M University System	Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function
WO2012007880A2 (en)	2010-07-16	2012-01-19	Ablynx Nv	Modified single domain antigen binding molecules and uses thereof
CA2807552A1 (en)	2010-08-06	2012-02-09	Moderna Therapeutics, Inc.	Engineered nucleic acids and methods of use thereof
KR102104762B1 (ko)	2010-08-13	2020-04-24	에일러론 테라퓨틱스 인코포레이티드	펩티도미메틱 거대고리
WO2012022734A2 (en)	2010-08-16	2012-02-23	Medimmune Limited	Anti-icam-1 antibodies and methods of use
US8916358B2 (en)	2010-08-31	2014-12-23	Greenlight Biosciences, Inc.	Methods for control of flux in metabolic pathways through protease manipulation
CA2810078A1 (en) *	2010-09-15	2012-03-22	Zogenix, Inc.	Needle-free injectors and design parameters thereof that optimize injection performance
WO2012035518A1 (en)	2010-09-17	2012-03-22	Compugen Ltd.	Compositions and methods for treatment of drug resistant multiple myeloma
CA2811023A1 (en)	2010-09-21	2012-03-29	Massachusetts Institute Of Technology	Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
WO2012040459A2 (en)	2010-09-22	2012-03-29	President And Fellows Of Harvard College	Beta-catenin targeting peptides and uses thereof
CN103153332A (zh)	2010-09-28	2013-06-12	卡尔医疗有限公司	用于治疗血液恶性肿瘤的组合物和方法
EP3219731A1 (de)	2010-10-01	2017-09-20	Oxford BioTherapeutics Ltd	Anti-ror1-antikörper
MX2013003599A (es)	2010-10-01	2013-07-29	Biogen Idec Inc	Interferon-beta para uso como monoterapia o en combinacion con otras terapias de cancer.
ES3005233T3 (en)	2010-10-01	2025-03-14	Modernatx Inc	Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
WO2012047941A2 (en)	2010-10-04	2012-04-12	Massachusetts Institute Of Technology	Hemagglutinin polypeptides, and reagents and methods relating thereto
JP2013543384A (ja)	2010-10-05	2013-12-05	ノバルティスアーゲー	抗−ｉｌ１２ｒベータ１抗体ならびに自己免疫性および炎症性疾患の処置おけるその使用
JP2013542788A (ja)	2010-11-03	2013-11-28	コンストラクトメディカルプロプライエタリーリミテッド	ポータブル真空装置
JP2013545749A (ja)	2010-11-10	2013-12-26	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環化合物及びその使用
MX338560B (es)	2010-11-24	2016-04-20	Glykos Finland Oy	Enzimas de fusion que tienen actividad de n-acetilglucosaminil transferasa.
GB201100282D0 (en)	2011-01-07	2011-02-23	Ucb Pharma Sa	Biological methods
US10208349B2 (en)	2011-01-07	2019-02-19	Ucb Biopharma Sprl	Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
AU2012205669B2 (en)	2011-01-10	2015-08-20	Infinity Pharmaceuticals Inc.	Processes for preparing isoquinolinones and solid forms of isoquinolinones
CA2824317C (en)	2011-01-19	2014-12-16	Terakine Therapeutics, Inc.	Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
EP2667945A1 (de)	2011-01-24	2013-12-04	Anterios, Inc.	Ölzusammensetzungen
TR201905477T4 (tr)	2011-01-24	2019-05-21	Anterios Inc	Nano-parçacık bileşimler.
JP5943258B2 (ja)	2011-01-24	2016-07-05	アンテリオス，インコーポレイテッド	ナノ粒子組成物、その製剤およびその使用
US9173999B2 (en)	2011-01-26	2015-11-03	Kaleo, Inc.	Devices and methods for delivering medicaments from a multi-chamber container
US8939943B2 (en)	2011-01-26	2015-01-27	Kaleo, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en)	2011-02-28	2014-01-14	Intelliject, Inc.	Medicament delivery device for administration of opioid antagonists including formulations for naloxone
EP2680837A4 (de)	2011-03-03	2015-06-03	Tersus Pharmaceuticals Llc	Zusammensetzungen und verfahren mit c16:1n7-palmitoleat
WO2012119989A2 (en)	2011-03-04	2012-09-13	Oryzon Genomics, S.A.	Methods and antibodies for the diagnosis and treatment of cancer
GB201103836D0 (en)	2011-03-07	2011-04-20	Glaxosmithkline Biolog Sa	Conjugation process
US20130281932A1 (en) *	2011-03-30	2013-10-24	Ziv Harish	Palm-based injector actuation and safety surfaces
WO2012135615A2 (en)	2011-03-30	2012-10-04	Brown University	Enopeptins, uses thereof, and methods of synthesis thereto
JP2014511687A (ja)	2011-03-31	2014-05-19	モデルナセラピューティクスインコーポレイテッド	工学操作された核酸の送達および製剤
US9409987B2 (en)	2011-04-15	2016-08-09	Compugen Ltd	Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
US20140163456A1 (en) *	2011-04-19	2014-06-12	Invisiderm, Llc	Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
SG194733A1 (en)	2011-05-17	2013-12-30	Glaxosmithkline Biolog Sa	Vaccine against streptococcus pneumoniae
US8691231B2 (en)	2011-06-03	2014-04-08	Merrimack Pharmaceuticals, Inc.	Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
JP2014519338A (ja)	2011-06-16	2014-08-14	ノバルティスアーゲー	治療薬として使用される可溶性タンパク質
CN103608030A (zh)	2011-06-21	2014-02-26	昂科发克特公司	用于治疗和诊断癌症的组合物和方法
US9845327B2 (en)	2011-06-22	2017-12-19	The General Hospital Corporation	Treatment of proteinopathies
CN103649121B (zh)	2011-06-28	2016-10-19	牛津生物疗法有限公司	针对adp-核糖基环化酶2的抗体
WO2013001517A1 (en)	2011-06-30	2013-01-03	Compugen Ltd.	Polypeptides and uses thereof for treatment of autoimmune disorders and infection
DK2726099T3 (en)	2011-07-01	2018-11-05	Novartis Ag	Method of treating metabolic disorders
JP6027610B2 (ja)	2011-07-19	2016-11-16	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環式化合物及びその使用
US9056877B2 (en)	2011-07-19	2015-06-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
TR201901856T4 (tr)	2011-07-22	2019-03-21	Massachusetts Inst Technology	Sınıf I histon deasetilazların (HDAC'ler) aktivatörleri ve kullanımları.
EP2736928B1 (de)	2011-07-28	2019-01-09	i2 Pharmaceuticals, Inc.	Gegen erbb3-gerichtete sur-bindende proteine
EP2751093A1 (de)	2011-08-29	2014-07-09	Infinity Pharmaceuticals, Inc.	Heterocyclische verbindungen und ihre verwendung
CN103930547A (zh)	2011-09-02	2014-07-16	诺华股份有限公司	用于治疗hsf1相关疾病的有机组合物
KR20150010932A (ko)	2011-09-09	2015-01-29	그린라이트 바이오사이언시스, 아이엔씨.	카바페넴의 무세포 제조법
US9550000B2 (en)	2011-09-09	2017-01-24	Lantheus Medical Imaging, Inc.	Compositions, methods, and systems for the synthesis and use of imaging agents
WO2013039861A2 (en)	2011-09-12	2013-03-21	modeRNA Therapeutics	Engineered nucleic acids and methods of use thereof
US20130071403A1 (en)	2011-09-20	2013-03-21	Vical Incorporated	Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
ES2806146T3 (es)	2011-09-22	2021-02-16	Amgen Inc	Proteínas de unión al antígeno CD27L
WO2013049332A1 (en)	2011-09-29	2013-04-04	Infinity Pharmaceuticals, Inc.	Inhibitors of monoacylglycerol lipase and methods of their use
EP2763701B1 (de)	2011-10-03	2018-12-19	Moderna Therapeutics, Inc.	Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
RU2474437C1 (ru) *	2011-10-13	2013-02-10	Борис Владимирович Смоляров	Способ осуществления безыгольной инъекции
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
EP2768518A4 (de)	2011-10-18	2015-05-27	Aileron Therapeutics Inc	Peptidomimetische makrozyklen
SI2776032T1 (sl)	2011-11-09	2018-12-31	Bristol-Myers Squibb Company	Zdravljenje hematoloških malignih obolenj z anti-CXCR4 protitelesom
TWI679212B (zh)	2011-11-15	2019-12-11	美商安進股份有限公司	針對ｂｃｍａ之e3以及ｃｄ３的結合分子
WO2013074986A1 (en)	2011-11-17	2013-05-23	Dana-Farber Cancer Institute, Inc.	Inhibitors of c-jun-n-terminal kinase (jnk)
US8603028B2 (en)	2011-11-18	2013-12-10	Allergan, Inc.	Injection device having an angled tip portion
GB201119999D0 (en)	2011-11-20	2012-01-04	Glaxosmithkline Biolog Sa	Vaccine
GB201120000D0 (en)	2011-11-20	2012-01-04	Glaxosmithkline Biolog Sa	Vaccine
BR112014014544A2 (pt)	2011-12-16	2017-06-13	Univ Florida	usos de análogos de 4'-desferritiocina
JP2015501844A (ja)	2011-12-16	2015-01-19	モデルナセラピューティクスインコーポレイテッドＭｏｄｅｒｎａＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
US8426471B1 (en)	2011-12-19	2013-04-23	Topokine Therapeutics, Inc.	Methods and compositions for reducing body fat and adipocytes
EP2793940B1 (de)	2011-12-22	2018-11-14	i2 Pharmaceuticals, Inc.	Surrogatbindungsproteine
GB201122305D0 (en)	2011-12-23	2012-02-01	Biotica Tech Ltd	Novel compound
US8242158B1 (en)	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
EP2800809B1 (de)	2012-01-05	2018-03-07	Glykos Finland Oy	Filamentöse pilzzellen mit proteasemangel und verwendungsverfahren dafür
EP2802658A2 (de)	2012-01-09	2014-11-19	Novartis AG	Rnai-wirkstoffe zur behandlung von erkrankungen im zusammenhang mit beta-catenin
US10130800B2 (en)	2012-01-27	2018-11-20	Invisiderm, Llc	Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
SG2014008304A (en)	2012-02-01	2014-06-27	Compugen Ltd	C10rf32 antibodies, and uses thereof for treatment of cancer
SMT201700137T1 (it)	2012-02-13	2017-05-08	Bristol Myers Squibb Co	Composti di endiini, loro coniugati, e loro usi e metodi
RU2642299C2 (ru)	2012-02-15	2018-01-24	Эйлерон Терапьютикс, Инк.	P53 пептидомиметические макроциклы
CA2864120A1 (en)	2012-02-15	2013-08-22	Aileron Therapeutics, Inc.	Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2013142796A2 (en)	2012-03-23	2013-09-26	Bristol-Myers Squibb Company	Methods of treatments using ctla4 antibodies
US20150050240A1 (en)	2012-03-27	2015-02-19	Novartis Ag	Treatment of fibrosis
CA2868459A1 (en)	2012-03-27	2013-10-03	Amicus Therapeutics, Inc.	Polymorphs of (3r,4r,5s)-5-(difluoromethyl)piperidine-3,4-diol fumarate and uses thereof
WO2013151697A1 (en)	2012-04-06	2013-10-10	President And Fellows Of Harvard College	Methods and compounds for identifying glycosyltransferase inhibitors
EP2850090B1 (de)	2012-04-06	2018-10-03	President and Fellows of Harvard College	Chemoenzymatische verfahren zur synthetisierung von moenomycin-analoga
US9273084B2 (en)	2012-04-06	2016-03-01	President And Fellows Of Harvard College	Moenomycin analogs, methods of synthesis, and uses thereof
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US10130714B2 (en)	2012-04-14	2018-11-20	Academia Sinica	Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
WO2013163176A1 (en)	2012-04-23	2013-10-31	Allertein Therapeutics, Llc	Nanoparticles for treatment of allergy
US20130304017A1 (en) *	2012-05-09	2013-11-14	Bioject, Inc.	Peformance of needle-free injection according to known relationships
WO2013167153A1 (en)	2012-05-09	2013-11-14	Ganymed Pharmaceuticals Ag	Antibodies useful in cancer diagnosis
CA2871160C (en)	2012-05-10	2023-03-14	Massachusetts Institute Of Technology	Agents for influenza neutralization
US9969794B2 (en)	2012-05-10	2018-05-15	Visterra, Inc.	HA binding agents
US9399672B2 (en)	2012-05-17	2016-07-26	The United States Of America, As Represented By The Secretary Department Of Health And Human Services	Hepatitis C virus neutralizing antibody
AR091069A1 (es)	2012-05-18	2014-12-30	Amgen Inc	Proteinas de union a antigeno dirigidas contra el receptor st2
US9522235B2 (en)	2012-05-22	2016-12-20	Kaleo, Inc.	Devices and methods for delivering medicaments from a multi-chamber container
DK2852610T3 (en)	2012-05-23	2018-09-03	Glykos Finland Oy	PRODUCTION OF FUCOSYLED GLYCOPROTEIN
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
US20150150963A1 (en)	2012-06-05	2015-06-04	The Australian National University	Vaccination with interleukin-4 antagonists
GB201210082D0 (en) *	2012-06-07	2012-07-25	Consort Medical Plc	Improved syringe
CN104619722B (zh)	2012-06-22	2022-10-04	达特茅斯大学理事会	新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途
US9890215B2 (en)	2012-06-22	2018-02-13	King's College London	Vista modulators for diagnosis and treatment of cancer
UY34887A (es)	2012-07-02	2013-12-31	Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware	Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
USD695892S1 (en)	2012-07-23	2013-12-17	Pharmajet, Inc.	Needle-free syringe
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
SG11201500573RA (en)	2012-08-06	2015-02-27	Glaxosmithkline Biolog Sa	Method for eliciting in infants an immune response against rsv and b. pertussis
US10309430B2 (en) *	2012-08-10	2019-06-04	Confluent Surgical, Inc.	Pneumatic actuation assembly
AU2013203000B9 (en)	2012-08-10	2017-02-02	Lantheus Medical Imaging, Inc.	Compositions, methods, and systems for the synthesis and use of imaging agents
WO2014028463A1 (en)	2012-08-14	2014-02-20	Allergan, Inc.	Syringe for mixing and dispensing adipose tissue
WO2014031498A1 (en)	2012-08-18	2014-02-27	Academia Sinica	Cell-permeable probes for identification and imaging of sialidases
CA2884704C (en)	2012-09-07	2023-04-04	Randolph J. Noelle	Vista modulators for diagnosis and treatment of cancer
RS61957B1 (sr)	2012-09-26	2021-07-30	Harvard College	Uvezani peptidi blokirani prolinom i njihove upotrebe
WO2014055564A1 (en)	2012-10-01	2014-04-10	President And Fellows Of Harvard College	Stabilized polypeptide insulin receptor modulators
HUE043853T2 (hu)	2012-10-12	2019-09-30	Broad Inst Inc	GSK3 inhibitorok és eljárások azok alkalmazására
US10112927B2 (en)	2012-10-18	2018-10-30	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 (CDK7)
US10000483B2 (en)	2012-10-19	2018-06-19	Dana-Farber Cancer Institute, Inc.	Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
US9758522B2 (en)	2012-10-19	2017-09-12	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged small molecules as inducers of protein degradation
US9675754B2 (en)	2012-10-24	2017-06-13	Nuance Designs, LLC	Autoinjector
WO2014065822A1 (en)	2012-10-26	2014-05-01	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Hepatitis c virus neutralizing epitopes, antibodies, and methods
KR102229478B1 (ko)	2012-11-01	2021-03-18	인피니티 파마슈티칼스, 인코포레이티드	Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
BR112015009470A2 (pt)	2012-11-01	2019-12-17	Aileron Therapeutics Inc	aminoácidos dissubstituídos e seus métodos de preparação e uso
EP2917203B1 (de)	2012-11-02	2019-04-03	Dana-Farber Cancer Institute, Inc.	Verfahren zur identifizierung von myc inhibitoren
AU2013344815B2 (en) *	2012-11-13	2018-07-26	Construct Medical Pty Ltd	A portable suction device
KR101651448B1 (ko)	2012-11-21	2016-08-26	토포카인 쎄라퓨틱스, 인코포레이티드	체지방을 국소적으로 증가시키는 방법 및 조성물
US9775915B2 (en)	2012-11-26	2017-10-03	President And Fellows Of Harvard College	Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
ES2921623T3 (es)	2012-11-26	2022-08-30	Modernatx Inc	ARN modificado terminalmente
PT2928923T (pt)	2012-12-10	2020-03-27	Biogen Ma Inc	Anticorpos antígenos 2 de células dendríticas anti-sangue e os seus usos
USD690416S1 (en)	2012-12-12	2013-09-24	Pharmajet, Inc.	Needle-free syringe
EP3626735A1 (de)	2012-12-18	2020-03-25	Novartis AG	Stabilisierte insulinähnliche wachstumsfaktorpolypeptide
WO2014100716A1 (en)	2012-12-21	2014-06-26	Epizyme, Inc.	Prmt5 inhibitors and uses thereof
US8993555B2 (en)	2012-12-21	2015-03-31	Epizyme, Inc.	PRMT5 inhibitors and uses thereof
US9745291B2 (en)	2012-12-21	2017-08-29	Epizyme, Inc.	PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US9908887B2 (en)	2012-12-21	2018-03-06	Epizyme, Inc.	PRMT5 inhibitors and uses thereof
GB2526948A (en)	2012-12-27	2015-12-09	Kaleo Inc	Systems for locating and interacting with medicament delivery devices
JP2016504050A (ja)	2013-01-17	2016-02-12	モデルナセラピューティクスインコーポレイテッドＭｏｄｅｒｎａＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
JO3519B1 (ar)	2013-01-25	2020-07-05	Amgen Inc	تركيبات أجسام مضادة لأجل cdh19 و cd3
EP2948478B1 (de)	2013-01-25	2019-04-03	Amgen Inc.	Antikörper gegen cdh19 für melanome
CA2898633C (en)	2013-02-07	2021-07-13	Massachusetts Institute Of Technology	Human adaptation of h5 influenza
CA2900008C (en)	2013-02-07	2025-10-07	Children's Medical Center Corporation	PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
MX371052B (es)	2013-02-08	2020-01-14	Novartis Ag	Anticuerpos anti-il-17a y su uso en el tratamiento de trastornos autoinmunes e inflamatorios.
LT2956173T (lt)	2013-02-14	2017-06-26	Bristol-Myers Squibb Company	Tubulizino junginiai, gavimo ir panaudojimo būdai
HK1218576A1 (zh)	2013-02-28	2017-02-24	Caprion Proteomics Inc.	结核病生物标志物及其用途
KR20150131244A (ko)	2013-03-13	2015-11-24	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	스테이플드 및 스티치드 폴리펩티드 및 그의 용도
US20160024181A1 (en)	2013-03-13	2016-01-28	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
KR20150129033A (ko)	2013-03-14	2015-11-18	애브비 인코포레이티드	저 산성 종 조성물 및 이의 제조 및 사용 방법
US9546203B2 (en)	2013-03-14	2017-01-17	Amgen Inc.	Aglycosylated Fc-containing polypeptides with cysteine substitutions
CA2899449A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	Low acidic species compositions and methods for producing the same using displacement chromatography
US20160024051A1 (en)	2013-03-15	2016-01-28	Infinity Pharmaceuticals, Inc.	Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
JP2016515120A (ja)	2013-03-15	2016-05-26	バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎＭＡＩｎｃ．	抗アルファｖベータ５抗体を用いた急性腎損傷の治療及び予防
WO2014144466A1 (en)	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Anti-alpha v beta 6 antibodies and uses thereof
EP2970449B1 (de)	2013-03-15	2019-09-25	Amgen Research (Munich) GmbH	Einkettige bindemoleküle mit n-terminalen ab
US9308236B2 (en)	2013-03-15	2016-04-12	Bristol-Myers Squibb Company	Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
WO2014140368A1 (en)	2013-03-15	2014-09-18	Amgen Research (Munich) Gmbh	Antibody constructs for influenza m2 and cd3
WO2014143739A2 (en)	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Anti-alpha v beta 6 antibodies and uses thereof
KR102233251B1 (ko)	2013-04-03	2021-03-26	엔-폴드 엘엘씨	신규 나노입자 조성물
JP6437523B2 (ja)	2013-04-04	2018-12-12	プレジデントアンドフェローズオブハーバードカレッジ	マクロライドならびにそれらの調製および使用の方法
US9381253B2 (en)	2013-04-09	2016-07-05	Massachusetts Institute Of Technology	Drug delivery polymer and uses thereof
US10301359B2 (en)	2013-04-30	2019-05-28	Massachusetts Institute Of Technology	Human adaptation of H3 influenza
WO2014179562A1 (en)	2013-05-01	2014-11-06	Massachusetts Institute Of Technology	1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
NO2753788T3 (de)	2013-05-10	2018-06-16
WO2014186504A1 (en)	2013-05-15	2014-11-20	Topokine Therapeutics, Inc.	Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US20140350518A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Syringe extrusion accessory
ES2834638T3 (es)	2013-05-30	2021-06-18	Infinity Pharmaceuticals Inc	Tratamiento de cánceres usando moduladores de isoforma de PI3 cinasa
SG11201508829QA (en)	2013-05-30	2015-12-30	Biogen Ma Inc	Oncostatin m receptor antigen binding proteins
WO2014197723A2 (en)	2013-06-05	2014-12-11	Massachusetts Institute Of Technology	Human adaptation of h7 ha
EP3030239A4 (de)	2013-06-11	2017-03-08	Kala Pharmaceuticals, Inc.	Harnstoffderivate und verwendungen davon
BR112015031277A2 (pt)	2013-06-14	2017-09-19	Harvard College	Moduladores do receptor de insulina de polipeptídeos estabilizados, análogos de insulina, composições farmacêuticas compreendendo os referidos polipeptídeos e métodos de preparação e usos dos mesmos
ES2909438T3 (es)	2013-06-26	2022-05-06	Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh	Enantiómero (S) de mepacina como inhibidor de paracaspasa (MALT1) para tratar cáncer
US10086054B2 (en)	2013-06-26	2018-10-02	Academia Sinica	RM2 antigens and use thereof
WO2014210564A1 (en)	2013-06-27	2014-12-31	Academia Sinica	Glycan conjugates and use thereof
WO2015013635A2 (en)	2013-07-25	2015-01-29	Dana-Farber Cancer Institute, Inc.	Inhibitors of transcription factors and uses thereof
WO2015021058A2 (en)	2013-08-05	2015-02-12	Greenlight Biosciences, Inc.	Engineered proteins with a protease cleavage site
AU2014304545A1 (en)	2013-08-05	2016-02-25	Glaxosmithkline Biologicals S.A.	Combination immunogenic compositions
TWI532511B (zh) *	2013-08-16	2016-05-11	京華堂實業股份有限公司	無針型注射系統及其注射方法
JP6486368B2 (ja)	2013-09-06	2019-03-20	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
TWI688401B (zh)	2013-09-13	2020-03-21	美商安進公司	用於治療骨髓性白血病的表觀遺傳因子與靶向ｃｄ３３及ｃｄ３之雙特異性化合物的組合
WO2015050959A1 (en)	2013-10-01	2015-04-09	Yale University	Anti-kit antibodies and methods of use thereof
BR112016005716A2 (pt)	2013-10-02	2017-09-12	Nat Institutes Of Health	miméticos de fator de crescimento semelhante à insulina para uso em terapia
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
PE20160685A1 (es)	2013-10-04	2016-07-23	Infinity Pharmaceuticals Inc	Compuestos heterociclicos y usos de los mismos
WO2015051234A2 (en)	2013-10-04	2015-04-09	Biogen Idec Ma Inc.	Tweak antagonists for treating lupus nephritis and muscle atrophy
SG11201602460QA (en)	2013-10-11	2016-04-28	Oxford Biotherapeutics Ltd	Conjugated antibodies against ly75 for the treatment of cancer
US9982009B2 (en)	2013-10-15	2018-05-29	Massachusetts Institute Of Technology	Methods for treating polycystic kidney disease and polycystic liver disease
US9902986B2 (en)	2013-10-16	2018-02-27	Massachusetts Institute Of Technology	Enterobactin conjugates and uses thereof
WO2015057939A1 (en)	2013-10-18	2015-04-23	Biogen Idec Ma Inc.	Anti-s1p4 antibodies and uses thereof
WO2015058140A1 (en)	2013-10-18	2015-04-23	Dana-Farber Cancer Institute, Inc.	Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
WO2015058126A1 (en)	2013-10-18	2015-04-23	Syros Pharmaceuticals, Inc.	Heteroaromatic compounds useful for the treatment of prolferative diseases
WO2015061204A1 (en)	2013-10-21	2015-04-30	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
WO2015066482A1 (en)	2013-11-01	2015-05-07	Kala Pharmaceuticals, Inc.	Crystalline forms of therapeutic compounds and uses thereof
UY35874A (es)	2013-12-12	2015-07-31	Novartis Ag	Un proceso para la preparación de una composición de proteínas pegiladas
EP4124624A3 (de)	2013-12-20	2023-05-03	Intervet International B.V.	Antikörper gegen hunde-pd-1
TWI670283B (zh)	2013-12-23	2019-09-01	美商建南德克公司	抗體及使用方法
US11014987B2 (en)	2013-12-24	2021-05-25	Janssen Pharmaceutics Nv	Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
EP4043493A1 (de)	2013-12-24	2022-08-17	Janssen Pharmaceutica NV	Anti-vista-antikörper und -fragmente
CA2934819A1 (en)	2013-12-24	2015-07-02	President And Fellows Of Harvard College	Cortistatin analogues and syntheses and uses thereof
US10150818B2 (en)	2014-01-16	2018-12-11	Academia Sinica	Compositions and methods for treatment and detection of cancers
TW201620939A (zh)	2014-01-16	2016-06-16	中央研究院	治療及檢測癌症之組合物及方法
WO2015117087A1 (en)	2014-01-31	2015-08-06	Dana-Farber Cancer Institute, Inc.	Uses of diazepane derivatives
US9598438B2 (en)	2014-02-12	2017-03-21	Amicus Therapeutics, Inc.	Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
CA2941357A1 (en)	2014-03-07	2015-09-11	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
SG10201808053XA (en)	2014-03-19	2018-10-30	Infinity Pharmaceuticals Inc	Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
EP3129767B1 (de)	2014-03-27	2021-09-01	Academia Sinica	Reaktive markierungsverbindungen und ihre verwendungen
DK3122375T3 (da)	2014-03-28	2021-05-25	Univ Washington Through Its Center For Commercialization	Vacciner mod bryst- og ovariecancer
US9675627B2 (en)	2014-04-14	2017-06-13	Amicus Therapeutics, Inc.	Dosing regimens for treating and/or preventing cerebral amyloidoses
US10017477B2 (en)	2014-04-23	2018-07-10	Dana-Farber Cancer Institute, Inc.	Janus kinase inhibitors and uses thereof
WO2015164604A1 (en)	2014-04-23	2015-10-29	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015168079A1 (en)	2014-04-29	2015-11-05	Infinity Pharmaceuticals, Inc.	Pyrimidine or pyridine derivatives useful as pi3k inhibitors
US10039816B2 (en)	2014-04-30	2018-08-07	Massachusetts Institute Of Technology	Siderophore-based immunization against gram-negative bacteria
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
EP3145523A4 (de)	2014-05-21	2018-02-21	President and Fellows of Harvard College	Ras-hemmerpeptide und verwendungen davon
AU2015267045B2 (en)	2014-05-27	2021-02-25	Academia Sinica	Anti-HER2 glycoantibodies and uses thereof
DK3149045T3 (da)	2014-05-27	2023-03-06	Academia Sinica	Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
US10118969B2 (en)	2014-05-27	2018-11-06	Academia Sinica	Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR20170003720A (ko)	2014-05-27	2017-01-09	아카데미아 시니카	항-ｃｄ20 글리코항체 및 이의 용도
JP7063538B2 (ja)	2014-05-28	2022-05-09	アカデミアシニカ	抗ＴＮＦα糖操作抗体群およびその使用
JP6612017B2 (ja) *	2014-06-03	2019-11-27	株式会社ダイセル	無針注射器による注射システム
AU2015271709B2 (en)	2014-06-06	2020-11-26	Bristol-Myers Squibb Company	Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
EP3154585B1 (de)	2014-06-11	2022-02-23	Kathy A. Green	Verwendung von vista-agonisten und antagonisten zur unterdrückung oder verbesserung der humoralen immunität
US11571472B2 (en)	2014-06-13	2023-02-07	Glaxosmithkline Biologicals Sa	Immunogenic combinations
MY186839A (en)	2014-06-19	2021-08-25	Takeda Pharmaceuticals Co	Heteroaryl compounds for kinase inhibition
EP2959931A1 (de)	2014-06-24	2015-12-30	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung
US20170291939A1 (en)	2014-06-25	2017-10-12	Novartis Ag	Antibodies specific for il-17a fused to hyaluronan binding peptide tags
US10188661B2 (en)	2014-06-27	2019-01-29	Topokine Therapeutics, Inc.	Topical dosage regimen
WO2016004202A1 (en)	2014-07-02	2016-01-07	Massachusetts Institute Of Technology	Polyamine-fatty acid derived lipidoids and uses thereof
US20170226552A1 (en)	2014-07-03	2017-08-10	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
WO2016007764A1 (en)	2014-07-09	2016-01-14	Abbvie Inc.	Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars
EP3169699A4 (de)	2014-07-18	2018-06-20	The University of Washington	Krebsimpfstoffzusammensetzungen und verfahren zur verwendung davon
US9517307B2 (en)	2014-07-18	2016-12-13	Kaleo, Inc.	Devices and methods for delivering opioid antagonists including formulations for naloxone
UY36245A (es)	2014-07-31	2016-01-29	Amgen Res Munich Gmbh	Constructos de anticuerpos para cdh19 y cd3
JP6749312B2 (ja)	2014-07-31	2020-09-02	アムゲンリサーチ（ミュンヘン）ゲーエムベーハーＡＭＧＥＮＲｅｓｅａｒｃｈ（Ｍｕｎｉｃｈ）ＧｍｂＨ	最適化された種間特異的二重特異性単鎖抗体コンストラクト
WO2016016415A1 (en)	2014-07-31	2016-02-04	Amgen Research (Munich) Gmbh	Bispecific single chain antibody construct with enhanced tissue distribution
EP2979714A1 (de)	2014-08-02	2016-02-03	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung aufweisend eine Membran
WO2016025331A1 (en)	2014-08-11	2016-02-18	University Of Massachusetts	Anti-ospa antibodies and methods of use
WO2016025643A1 (en)	2014-08-12	2016-02-18	Massachusetts Institute Of Technology	Brush-poly(glycoamidoamine)-lipids and uses thereof
CR20170060A (es)	2014-08-19	2017-04-18	Merck Sharp & Dohme	Anticuerpos anti tigit
JO3663B1 (ar)	2014-08-19	2020-08-27	Merck Sharp & Dohme	الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
US20170275344A1 (en)	2014-08-26	2017-09-28	Compugen Ltd.	Polypeptides and uses thereof as a drug for treatment of autoimmune disorders
EP2993174A1 (de)	2014-09-08	2016-03-09	Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH	Pyrazolopyridinderivate und deren Verwendung in der Therapie
EP3191500A4 (de)	2014-09-08	2018-04-11	Academia Sinica	Aktivierung menschlicher inkt-zellen mithilfe von glykolipiden
CN107106642B (zh)	2014-09-24	2021-02-26	艾瑞朗医疗公司	拟肽大环化合物及其制剂
EP3197478A4 (de)	2014-09-24	2018-05-30	Aileron Therapeutics, Inc.	Peptidomimetische makrozyklen und verwendungen davon
US10226585B2 (en)	2014-10-01	2019-03-12	Allergan, Inc.	Devices for injection and dosing
SG10201902924RA (en)	2014-10-03	2019-05-30	Massachusetts Inst Technology	Antibodies that bind ebola glycoprotein and uses thereof
US9708348B2 (en)	2014-10-03	2017-07-18	Infinity Pharmaceuticals, Inc.	Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
US9732119B2 (en)	2014-10-10	2017-08-15	Bristol-Myers Squibb Company	Immunomodulators
KR102331856B1 (ko)	2014-10-21	2021-11-29	다케다 야쿠힌 고교 가부시키가이샤	결정 형태의 5-클로로-n4-[2-(디메틸포스포릴)페닐]-n2-｛2-메톡시-4-[4-(4-메틸피페라진-1-일)피페리딘-1-일]피리미딘-2,4-디아민
EP3011988A1 (de)	2014-10-22	2016-04-27	LTS LOHMANN Therapie-Systeme AG	Nadellose Injektionsvorrichtung aufweisend ein Gel und eine Membran
WO2016066618A2 (en)	2014-10-28	2016-05-06	INSERM (Institut National de la Santé et de la Recherche Médicale)	Compositions and methods for antigen-specific tolerance
WO2016077125A1 (en)	2014-11-10	2016-05-19	Moderna Therapeutics, Inc.	Alternative nucleic acid molecules containing reduced uracil content and uses thereof
WO2016075137A1 (en)	2014-11-10	2016-05-19	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
US10077287B2 (en)	2014-11-10	2018-09-18	Bristol-Myers Squibb Company	Tubulysin analogs and methods of making and use
US9856292B2 (en)	2014-11-14	2018-01-02	Bristol-Myers Squibb Company	Immunomodulators
TWI711630B (zh)	2014-11-21	2020-12-01	美商必治妥美雅史谷比公司	抗ｃｄ７３抗體及其用途
PL3221346T3 (pl)	2014-11-21	2021-03-08	Bristol-Myers Squibb Company	Przeciwciała ze zmodyfikowanym regionem stałym łańcucha ciężkiego
US10253045B2 (en)	2014-11-26	2019-04-09	Kala Pharmaceuticals, Inc.	Crystalline forms of a therapeutic compound and uses thereof
WO2016087514A1 (en)	2014-12-02	2016-06-09	Cemm - Forschungszentrum Für Molekulare Medizin Gmbh	Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies
JP2018505911A (ja)	2014-12-05	2018-03-01	イミュネクスト，インコーポレーテッド	推定上のｖｉｓｔａ受容体としてのｖｓｉｇ８の同定と、ｖｉｓｔａ／ｖｓｉｇ８調節剤を産生するためのその使用
EP3230272B1 (de)	2014-12-10	2020-08-19	Kala Pharmaceuticals, Inc.	1-amino-triazol(1,5-a)pyridin-substituiertes harnstoffderivat und verwendungen davon
US9861680B2 (en)	2014-12-18	2018-01-09	Bristol-Myers Squibb Company	Immunomodulators
CN107278206B (zh)	2014-12-19	2021-04-02	雷根尼桑斯公司	结合人c6的抗体及其用途
KR102554779B1 (ko)	2014-12-23	2023-07-11	슬로안-케테링인스티튜트퍼캔서리서치	그라나티신 b의 다형체
AU2015371251B2 (en)	2014-12-23	2020-06-11	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 (CDK7)
MY187045A (en)	2014-12-23	2021-08-27	Bristol Myers Squibb Co	Antibodies to tigit
EP3242685B1 (de)	2015-01-09	2022-05-04	AdAlta Limited	Cxcr4-bindende moleküle
KR20170102981A (ko)	2015-01-14	2017-09-12	브리스톨-마이어스 스큅 컴퍼니	헤테로아릴렌-가교된 벤조디아제핀 이량체, 그의 접합체, 및 제조 및 사용 방법
US9975965B2 (en)	2015-01-16	2018-05-22	Academia Sinica	Compositions and methods for treatment and detection of cancers
US10495645B2 (en)	2015-01-16	2019-12-03	Academia Sinica	Cancer markers and methods of use thereof
US10342858B2 (en)	2015-01-24	2019-07-09	Academia Sinica	Glycan conjugates and methods of use thereof
US20160222060A1 (en)	2015-02-04	2016-08-04	Bristol-Myers Squibb Company	Immunomodulators
US10983128B2 (en)	2015-02-05	2021-04-20	Bristol-Myers Squibb Company	CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
WO2016144773A1 (en)	2015-03-06	2016-09-15	Abbvie Inc.	Arabinosylated glycoproteins
EP3268037B1 (de)	2015-03-09	2022-08-31	Celldex Therapeutics, Inc.	Cd27 agonists
BR112017019272A2 (pt)	2015-03-10	2018-05-02	Allergan Pharmaceuticals Holdings Ireland Unlimited Company	injetor de múltiplas agulhas
US9809625B2 (en)	2015-03-18	2017-11-07	Bristol-Myers Squibb Company	Immunomodulators
JP2018511655A (ja)	2015-03-20	2018-04-26	ザリージェンツオブザユニバーシティオブミシガン	ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
JP2018516844A (ja)	2015-03-20	2018-06-28	エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	ペプチド模倣大環状分子およびその使用
EP3274021B1 (de)	2015-03-24	2024-02-14	Kaleo, Inc.	Vorrichtungen und verfahren zur abgabe eines lyophilisierten medikaments
CN107427521B (zh)	2015-03-27	2021-08-03	达纳-法伯癌症研究所股份有限公司	细胞周期蛋白依赖性激酶的抑制剂
BR112017020690A2 (pt)	2015-03-30	2018-06-26	Greenlight Biosciences Inc	produção livre de células de ácido ribonucleico
JP6938383B2 (ja)	2015-04-02	2021-09-22	インターベットインターナショナルベー．フェー．	イヌインターロイキン４受容体アルファに対する抗体
MX2017012966A (es)	2015-04-10	2018-06-06	Amgen Inc	Muteinas de interleuquina 2 para la expansion de celulas t regulatorias.
JP2018510913A (ja)	2015-04-10	2018-04-19	ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー	抗ウイルス剤としての使用のためのピロン誘導体
DK3283524T3 (da)	2015-04-17	2023-05-30	Amgen Res Munich Gmbh	BISPECIFIKKE ANTISTOFKONSTRUKTIONER MOD CDH3 og CD3
WO2016176343A1 (en)	2015-04-27	2016-11-03	University Of Florida Research Foundation, Incorporated	Metabolically programmed metal chelators and uses thereof
EP3288584A2 (de)	2015-04-30	2018-03-07	President and Fellows of Harvard College	Anti-ap2-antikörper und antigenbindemittel zur behandlung von stoffwechselerkrankungen
WO2016178591A2 (en)	2015-05-05	2016-11-10	Gene Predit, Sa	Genetic markers and treatment of male obesity
CA2985816A1 (en)	2015-05-15	2016-11-24	The General Hospital Corporation	Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
EP3297676A2 (de)	2015-05-22	2018-03-28	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Kombination aus trpm8-agonist und nachr-agonist zur behandlung von obesitas und verwandten erkrankungen sowie zur gewichtsreduzierung
JP6851322B2 (ja)	2015-05-27	2021-03-31	ユーシービーバイオファルマエスアールエル	神経疾患を治療する方法
WO2016196895A1 (en) *	2015-06-05	2016-12-08	Joslin Diabetes Center, Inc.	Methods amd compositions for promoting thermogenic potential
EP3307728A4 (de)	2015-06-12	2019-07-17	Dana Farber Cancer Institute, Inc.	Kombinationstherapie von transkriptionshemmern und kinasehemmern
EP3307348A2 (de) *	2015-06-15	2018-04-18	Nuance Designs of CT, LLC	Gasbetriebener autoinjektor mit gasdurchflussregler
JP2017000667A (ja)	2015-06-16	2017-01-05	国立大学法人三重大学	無針注射器及びそれを用いた注射対象領域へのｄｎａ導入方法
ES2949540T3 (es)	2015-06-19	2023-09-29	Massachusetts Inst Technology	2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula
EP3722314A1 (de)	2015-06-24	2020-10-14	Janssen Pharmaceutica NV	Anti-vista-antikörper und -fragmente
UY36751A (es)	2015-06-26	2017-01-31	Novartis Ag	Anticuerpos de factor xi y métodos de uso
US10479838B2 (en)	2015-06-29	2019-11-19	Bristol-Myers Squibb Company	Antibodies to CD40 with enhanced agonist activity
AU2016287571C1 (en)	2015-06-30	2021-12-23	Kaleo, Inc.	Auto-injectors for administration of a medicament within a prefilled syringe
US10059741B2 (en)	2015-07-01	2018-08-28	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles
CA2991980A1 (en)	2015-07-13	2017-01-19	Compugen Ltd.	Hide1 compositions and methods
TWI744242B (zh)	2015-07-31	2021-11-01	德商安美基研究（慕尼黑）公司	Egfrviii及cd3抗體構築體
EA039859B1 (ru)	2015-07-31	2022-03-21	Эмджен Рисерч (Мюник) Гмбх	Биспецифические конструкты антител, связывающие egfrviii и cd3
TWI796283B (zh)	2015-07-31	2023-03-21	德商安美基研究（慕尼黑）公司	Ｍｓｌｎ及ｃｄ３抗體構築體
TWI717375B (zh)	2015-07-31	2021-02-01	德商安美基研究（慕尼黑）公司	Ｃｄ７０及ｃｄ３抗體構築體
TWI793062B (zh)	2015-07-31	2023-02-21	德商安美基研究（慕尼黑）公司	Ｄｌｌ３及ｃｄ３抗體構築體
TWI829617B (zh)	2015-07-31	2024-01-21	德商安美基研究（慕尼黑）公司	Ｆｌｔ３及ｃｄ３抗體構築體
JO3620B1 (ar)	2015-08-05	2020-08-27	Amgen Res Munich Gmbh	مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم
US10179128B2 (en)	2015-08-31	2019-01-15	Amicus Therapeutics, Inc.	Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
JP7028766B2 (ja)	2015-09-09	2022-03-02	ダナ－ファーバーキャンサーインスティテュート，インコーポレイテッド	サイクリン依存性キナーゼの阻害剤
EP3347372A4 (de)	2015-09-10	2019-09-04	Aileron Therapeutics, Inc.	Peptidomimetische makrocyclen als modulatoren von mcl-1
US10160761B2 (en)	2015-09-14	2018-12-25	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
RS63030B1 (sr)	2015-09-17	2022-04-29	Modernatx Inc	Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
SI3350333T1 (sl)	2015-09-17	2022-04-29	ModernaTX,Inc.	Polinukleotidi, ki zajemajo stabilizacijsko repno regijo
RU2638457C2 (ru)	2015-09-28	2017-12-13	Общество С Ограниченной Ответственностью "Онкомакс"	Антитела, специфически связывающие рецептор 1 типа фактора роста фибробластов, применение антител для лечения онкологического заболевания, способ получения антител
EP3355914B1 (de)	2015-09-29	2024-03-06	The General Hospital Corporation	Eine bcg-haltige zusammensetzung zur cholesterolsenkung.
PT3356386T (pt)	2015-09-30	2024-05-17	Rhythm Pharmaceuticals Inc	Método de tratamento de distúrbios associados à via do receptor da melanocortina-4
US9925170B2 (en)	2015-10-01	2018-03-27	Kythera Biopharmaceuticals, Inc.	Methods of adipolysis and compositions useful therein
GB201518684D0 (en)	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
JO3555B1 (ar)	2015-10-29	2020-07-05	Merck Sharp & Dohme	جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
CN108602884B (zh)	2015-11-08	2024-06-25	豪夫迈·罗氏有限公司	筛选多特异性抗体的方法
EP3374390A1 (de)	2015-11-13	2018-09-19	Visterra, Inc.	Zusammensetzungen und verfahren zur behandlung und vorbeugung von grippe
CA3005855A1 (en)	2015-11-19	2017-05-26	Bristol-Myers Squibb Company	Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
AR108824A1 (es)	2015-11-21	2018-10-03	Fundacio Privada Inst De Recerca De La Sida Caixa Irsicaixa	Derivados de anticuerpos contra el vih con actividad dual antiviral e inmunomodulatoria
KR102630475B1 (ko)	2015-11-30	2024-01-26	브리스톨-마이어스 스큅 컴퍼니	항 인간 ip-10 항체 및 이의 용도
ES2975747T3 (es)	2015-11-30	2024-07-12	Univ California	Administración de carga útil específica de tumor y activación inmunitaria utilizando un anticuerpo humano que se dirige a un antígeno de superficie celular de tumor altamente específico
CA3006779A1 (en)	2015-12-09	2017-06-15	Admedus Vaccines Pty Ltd	Immunomodulating composition for treatment
CA3005696A1 (en)	2015-12-18	2017-06-22	Intervet International B.V.	Caninized human antibodies to human and canine il-4r alpha
JP7114465B2 (ja)	2015-12-22	2022-08-08	モデルナティエックスインコーポレイテッド	薬剤の細胞内送達のための化合物および組成物
RU2021129189A (ru)	2016-01-22	2021-11-15	Мерк Шарп И Доум Корп.	Антитела против фактора свертывания xi
JOP20170017B1 (ar)	2016-01-25	2021-08-17	Amgen Res Munich Gmbh	تركيب صيدلي يتضمن تركيبات جسم مضاد ثنائي الاختصاص
CA3011942A1 (en)	2016-02-03	2017-08-10	Amgen Research (Munich) Gmbh	Psma and cd3 bispecific t cell engaging antibody constructs
SG11201805770UA (en)	2016-02-03	2018-08-30	Amgen Res Munich Gmbh	BCMA and CD3 Bispecific T Cell Engaging Antibody Constructs
TW202216201A (zh)	2016-02-12	2022-05-01	比利時商楊森製藥公司	抗vista抗體及片段、其用途及鑑定其之方法
KR20180107151A (ko)	2016-02-17	2018-10-01	노파르티스 아게	Tgf베타 2 항체
EP3419663A1 (de)	2016-02-24	2019-01-02	Visterra, Inc.	Formulierungen von antikörpermolekülen gegen influenzavirus
KR20180114223A (ko)	2016-03-04	2018-10-17	더 락커펠러 유니버시티	증진된 효능제 활성을 갖는 cd40에 대한 항체
US10143746B2 (en)	2016-03-04	2018-12-04	Bristol-Myers Squibb Company	Immunomodulators
CA3016187A1 (en)	2016-03-04	2017-09-08	Bristol-Myers Squibb Company	Combination therapy with anti-cd73 antibodies
AU2017231749A1 (en)	2016-03-08	2018-09-20	Academia Sinica	Methods for modular synthesis of N-glycans and arrays thereof
WO2017161116A1 (en)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
NZ747635A (en)	2016-03-28	2024-05-31	Ichor Medical Systems Inc	Method and apparatus for delivery of therapeutic agents
US10358463B2 (en)	2016-04-05	2019-07-23	Bristol-Myers Squibb Company	Immunomodulators
SG11201808721YA (en)	2016-04-06	2018-11-29	Greenlight Biosciences Inc	Cell-free production of ribonucleic acid
US10596321B2 (en)	2016-04-08	2020-03-24	Allergan, Inc.	Aspiration and injection device
JP7184751B2 (ja)	2016-04-15	2022-12-06	イミュネクストインコーポレイテッド	抗ヒトｖｉｓｔａ抗体およびその使用
JP7038064B2 (ja)	2016-04-18	2022-03-17	セルデックスセラピューティクスインコーポレイテッド	ヒトｃｄ４０に結合するアゴニスト抗体およびその使用
WO2017184586A1 (en)	2016-04-18	2017-10-26	The Trustees Of Columbia University In The City Of New York	Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (nash)
JOP20170091B1 (ar)	2016-04-19	2021-08-17	Amgen Res Munich Gmbh	إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
CA3019588A1 (en)	2016-04-20	2017-10-26	Merck Sharp & Dohme Corp.	Cmv neutralizing antigen binding proteins
AU2017251983B2 (en)	2016-04-22	2023-07-20	BioNTech SE	Methods for providing single-stranded RNA
EP3932453B1 (de) *	2016-04-29	2025-11-05	Altaviz LLC	Selbständig energieversorgte spritze
CN115073581A (zh)	2016-05-04	2022-09-20	美国安进公司	用于扩增t调节性细胞的白细胞介素-2突变蛋白
US10968279B2 (en)	2016-05-09	2021-04-06	Bristol-Myers Squibb Company	TL1A antibodies and uses thereof
TW201802121A (zh)	2016-05-25	2018-01-16	諾華公司	抗因子XI/XIa抗體之逆轉結合劑及其用途
EP3464327A1 (de)	2016-06-03	2019-04-10	Sanofi Pasteur Inc.	Modifizierung von manipulierten influenza-hämagglutinin-polypeptide
WO2017214337A1 (en)	2016-06-07	2017-12-14	Massachusetts Institute Of Technology	Drug delivery polymers and uses thereof
US10919914B2 (en)	2016-06-08	2021-02-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
WO2017218704A1 (en)	2016-06-14	2017-12-21	Modernatx, Inc.	Stabilized formulations of lipid nanoparticles
MY201852A (en)	2016-06-14	2024-03-20	Merck Sharp & Dohme Llc	Anti-coagulation factor xi antibodies
US20180002417A1 (en)	2016-06-15	2018-01-04	Celimmune Llc	Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
GB201610599D0 (en)	2016-06-17	2016-08-03	Glaxosmithkline Biologicals Sa	Immunogenic Composition
US10328205B2 (en) *	2016-07-07	2019-06-25	Shl Medical Ag	Drug delivery device with pneumatic power pack
SG11201900026TA (en)	2016-07-14	2019-01-30	Bristol Myers Squibb Co	Antibodies against tim3 and uses thereof
WO2018018082A1 (en)	2016-07-26	2018-02-01	The Australian National University	Immunostimulatory compositions and uses therefor
US20180028755A1 (en)	2016-07-28	2018-02-01	Portal Instruments, Inc.	Connected health platform including needle-free injector system
NL2017267B1 (en)	2016-07-29	2018-02-01	Aduro Biotech Holdings Europe B V	Anti-pd-1 antibodies
NL2017270B1 (en)	2016-08-02	2018-02-09	Aduro Biotech Holdings Europe B V	New anti-hCTLA-4 antibodies
CA3032146A1 (en)	2016-08-03	2018-02-08	Bio-Techne Corporation	Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy
NL2017294B1 (en)	2016-08-05	2018-02-14	Univ Erasmus Med Ct Rotterdam	Natural cryptic exon removal by pairs of antisense oligonucleotides.
SG11201900794PA (en)	2016-08-05	2019-02-27	Sanofi Pasteur Inc	Multivalent pneumococcal polysaccharide-protein conjugate composition
TWI770044B (zh)	2016-08-05	2022-07-11	南韓商Ｓｋ生物科技股份有限公司	多價肺炎球菌多醣-蛋白質共軛物組成物(一)
ES2902179T3 (es)	2016-08-19	2022-03-25	Bristol Myers Squibb Co	Compuestos de seco-ciclopropapirroloindol, conjugados de anticuerpo-fármaco de los mismos y métodos de elaboración y uso
AU2017316663B2 (en)	2016-08-22	2024-02-22	CHO Pharma Inc.	Antibodies, binding fragments, and methods of use
WO2018035710A1 (en)	2016-08-23	2018-03-01	Akeso Biopharma, Inc.	Anti-ctla4 antibodies
US10981976B2 (en)	2016-08-31	2021-04-20	University Of Rochester	Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
JOP20190055A1 (ar)	2016-09-26	2019-03-24	Merck Sharp & Dohme	أجسام مضادة ضد cd27
EP3305781A1 (de)	2016-10-07	2018-04-11	Deutsches Krebsforschungszentrum	Chemische substanzen welche die enzymatische aktivität der humanen kallikrein-related peptidase 6 (klk6) hemmen.
CA3040189A1 (en)	2016-10-13	2018-04-19	Massachusetts Institute Of Technology	Antibodies that bind zika virus envelope protein and uses thereof
CN110352073A (zh)	2016-10-28	2019-10-18	机敏医药股份有限公司	针对timp-2的抗体用于改善肾功能的用途
EP3535280B1 (de)	2016-11-07	2022-03-16	Bristol-Myers Squibb Company	Immunomodulatoren
US11583504B2 (en)	2016-11-08	2023-02-21	Modernatx, Inc.	Stabilized formulations of lipid nanoparticles
WO2018089829A1 (en)	2016-11-10	2018-05-17	Fortis Therapeutics, Inc.	Cd46-specific effector cells and uses thereof
WO2018089807A2 (en)	2016-11-11	2018-05-17	The Regents Of The University Of California	Anti-cd46 antibodies and methods of use
CA3043131A1 (en)	2016-11-18	2018-05-24	Neurovive Pharmaceutical Ab	Use of sanglifehrin macrocyclic analogues as anticancer compounds
WO2018106738A1 (en)	2016-12-05	2018-06-14	Massachusetts Institute Of Technology	Brush-arm star polymers, conjugates and particles, and uses thereof
US10961305B2 (en)	2016-12-21	2021-03-30	Mereo Biopharma 3 Limited	Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
MX2019007161A (es)	2016-12-21	2020-02-12	Mereo Biopharma 3 Ltd	Uso de anticuerpos anti-esclerostina en el tratamiento de osteogenesis imperfecta.
BR112019012667A2 (pt)	2016-12-23	2020-02-11	Novartis Ag	Anticorpos do fator xi e métodos de uso
WO2018119218A1 (en)	2016-12-23	2018-06-28	Kaleo, Inc.	Medicament delivery device and methods for delivering drugs to infants and children
SG10202107367SA (en)	2016-12-31	2021-08-30	Bioxcel Therapeutics Inc	Use of sublingual dexmedetomidine for the treatment of agitation
PL3565828T3 (pl)	2017-01-05	2022-04-04	Kahr Medical Ltd.	Białko fuzyjne SIRP1 ALFA-41BBL i sposoby jego zastosowania
RU2769513C2 (ru)	2017-01-05	2022-04-01	Кахр Медикал Лтд.	Слитый белок pd1-4-1bbl и способы его применения
TW201833140A (zh)	2017-01-09	2018-09-16	美商莫瑞麥克製藥公司	抗fgfr抗體及使用方法
WO2018136413A2 (en)	2017-01-17	2018-07-26	Kaleo, Inc.	Medicament delivery devices with wireless connectivity and event detection
US11377497B2 (en)	2017-01-23	2022-07-05	Suzhou Alphamab Co., Ltd.	PD-L1 binding polypeptide or composite
WO2018140510A1 (en)	2017-01-25	2018-08-02	Biogen Ma Inc.	Compositions and methods for treatment of stroke and other cns disorders
AU2018214223B2 (en)	2017-02-02	2025-08-14	Amgen Inc.	Low pH pharmaceutical composition comprising T cell engaging antibody constructs
GB2559553B (en) *	2017-02-06	2021-10-13	Consort Medical Plc	A medicament delivery device
GB201702144D0 (en)	2017-02-09	2017-03-29	Annexin Pharmaceuticals Ab	Therapeutic compositions
JP2020507632A (ja)	2017-02-10	2020-03-12	マウントタムセラピューティクス, インコーポレイテッドMount Tam Therapeutics, Inc.	ラパマイシン類似体
EA201991720A1 (ru)	2017-02-17	2020-01-20	Бристол-Маерс Сквибб Компани	Антитела к альфа-синуклеину и их применения
GB201703876D0 (en)	2017-03-10	2017-04-26	Berlin-Chemie Ag	Pharmaceutical combinations
KR20190132405A (ko)	2017-03-15	2019-11-27	모더나티엑스, 인크.	치료제의 세포내 전달을 위한 화합물 및 조성물
ES3020935T3 (en)	2017-03-15	2025-05-23	Modernatx Inc	Lipid nanoparticle formulation
EP3601326A4 (de)	2017-03-20	2020-12-16	The Broad Institute, Inc.	Verbindungen und verfahren zur regulierung der insulinsekretion
USD867582S1 (en)	2017-03-24	2019-11-19	Allergan, Inc.	Syringe device
WO2018187630A1 (en)	2017-04-05	2018-10-11	The Broad Institute, Inc.	Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
TWI796329B (zh)	2017-04-07	2023-03-21	美商默沙東有限責任公司	抗－ilt4抗體及抗原結合片段
TWI788340B (zh)	2017-04-07	2023-01-01	美商必治妥美雅史谷比公司	抗icos促效劑抗體及其用途
WO2018190719A2 (en)	2017-04-13	2018-10-18	Aduro Biotech Holdings, Europe B.V.	Anti-sirp alpha antibodies
WO2018200618A1 (en)	2017-04-25	2018-11-01	Amicus Therapeutics, Inc.	Novel compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders
KR102700015B1 (ko)	2017-05-05	2024-08-29	암젠 인크	개선된 저장 및 투여를 위한 이중특이적 항체 구축물을 포함하는 약제학적 조성물
JP2020519309A (ja)	2017-05-10	2020-07-02	アルバジュナ・セラピューティクス・エセ・エレ	高い二重のＨＩＶ抗ウイルス及び免疫調節活性を有するＦｃ融合タンパク質誘導体
CN111094335B (zh)	2017-05-15	2022-08-23	罗切斯特大学	广泛中和的抗流感单克隆抗体及其用途
US20200299400A1 (en)	2017-05-25	2020-09-24	Bristol-Myers Squibb Company	Antibodies comprising modified heavy constant regions
US12077501B2 (en)	2017-06-14	2024-09-03	Modernatx, Inc.	Compounds and compositions for intracellular delivery of agents
KR102735038B1 (ko)	2017-06-23	2024-11-28	브리스톨-마이어스 스큅 컴퍼니	Pd-1의 길항제로서 작용하는 면역조정제
MX2019015524A (es)	2017-06-23	2020-09-10	Univ Maryland	Composiciones inmunogenicas.
EP3650469A4 (de)	2017-06-23	2021-03-24	Suzhou Bojuhua Biomedical Technology Co. Ltd	Monoklonaler antikörper gezielter menschlicher tumorstammzellen und anwendung des monoklonalen antikörpers
WO2019013789A1 (en)	2017-07-12	2019-01-17	Curza Global, Llc	ANTIMICROBIAL COMPOUNDS
WO2019013790A1 (en)	2017-07-12	2019-01-17	Curza Global, Llc	ANTIMICROBIAL COMPOUNDS AND USES THEREOF
GB201711635D0 (en)	2017-07-19	2017-08-30	Glaxosmithkline Biologicals Sa	Immunogenic composition
AU2018322475A1 (en)	2017-08-22	2020-03-05	Biogen Ma Inc.	Pharmaceutical compositions and dosage regimens containing anti-alpha(v)beta(6) antibodies
CA3074128A1 (en)	2017-08-28	2019-03-07	Shanghai Yile Biotechnology Co., Ltd.	Polypeptide and antibody bound to polypeptide
GB2584009B (en)	2017-08-28	2022-03-23	Revagenix Inc	Aminoglycosides and uses thereof
WO2019046809A1 (en)	2017-08-31	2019-03-07	Modernatx, Inc.	METHODS OF MANUFACTURING LIPID NANOPARTICLES
EP3692053A1 (de)	2017-10-03	2020-08-12	Bristol-Myers Squibb Company	Immunmodulatoren
SG11202003114UA (en)	2017-10-04	2020-05-28	Amgen Inc	Transthyretin immunoglobulin fusions
EP3694552A1 (de)	2017-10-10	2020-08-19	Tilos Therapeutics, Inc.	Anti-lap-antikörper und verwendungen davon
JP7792196B2 (ja)	2017-10-11	2025-12-25	グリーンライトバイオサイエンシーズインコーポレーテッド	ヌクレオシド三リン酸およびリボ核酸の生成のための方法および組成物
US12441998B2 (en)	2017-10-12	2025-10-14	The Trustees Of Columbia University In The City Of New York	SLC2A1 lncRNA as a biologic and related treatments and methods
EP3700938A1 (de)	2017-10-26	2020-09-02	ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.	Neuartige rekombinante fusionsproteine, herstellung und verwendung davon
KR20240171186A (ko)	2017-10-26	2024-12-06	다케다 야쿠힌 고교 가부시키가이샤	글루코세레브로시다제 및 이소파고민을 포함하는 제제
CN111542544A (zh)	2017-11-01	2020-08-14	百时美施贵宝公司	用于治疗癌症的免疫刺激性激动性抗体
KR102478433B1 (ko)	2017-11-17	2022-12-15	머크 샤프 앤드 돔 엘엘씨	이뮤노글로불린-유사 전사체 3 (ilt3)에 대해 특이적인 항체 및 그의 용도
WO2019109079A1 (en)	2017-12-01	2019-06-06	North Carolina State University	Fibrin particles and methods of making the same
TWI827570B (zh)	2017-12-11	2024-01-01	美商安進公司	雙特異性抗體產品之連續製造製程
EP3728200A1 (de)	2017-12-21	2020-10-28	Gliapharm SA	Zusammensetzungen und verfahren zur behandlung von neurologischen störungen einschliesslich motoneuronenerkrankungen
JP2021507945A (ja)	2017-12-21	2021-02-25	グリアファームエスエー	認知症を含む神経障害のための組成物および治療方法
GB201721576D0 (en)	2017-12-21	2018-02-07	Glaxosmithkline Biologicals Sa	Hla antigens and glycoconjugates thereof
GB201721582D0 (en)	2017-12-21	2018-02-07	Glaxosmithkline Biologicals Sa	S aureus antigens and immunogenic compositions
WO2019126766A1 (en) *	2017-12-21	2019-06-27	Taiwan Liposome Co., Ltd.	Sustained-release triptan compositions and method of use the same through subdermal route or the like
JP7284759B2 (ja)	2017-12-27	2023-05-31	ブリストル－マイヤーズスクイブカンパニー	抗ｃｄ４０抗体およびその使用
UY38041A (es)	2017-12-29	2019-06-28	Amgen Inc	Construcción de anticuerpo biespecífico dirigida a muc17 y cd3
WO2019139987A1 (en)	2018-01-09	2019-07-18	Elstar Therapeutics, Inc.	Calreticulin binding constructs and engineered t cells for the treatment of diseases
JP7358361B2 (ja)	2018-01-12	2023-10-10	ブリストル－マイヤーズスクイブカンパニー	Ｔｉｍ３に対する抗体およびその使用
WO2019148412A1 (en)	2018-02-01	2019-08-08	Merck Sharp & Dohme Corp.	Anti-pd-1/lag3 bispecific antibodies
EP3746477A1 (de)	2018-02-02	2020-12-09	Bio-Techne Corporation	Verbindungen, die die wechselwirkung von vista und vsig3 modulieren, und verfahren zur herstellung und verwendung
BR112020014978A2 (pt)	2018-02-05	2020-12-22	Sanofi Pasteur, Inc.	Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
KR20230008923A (ko)	2018-02-05	2023-01-16	사노피 파스퇴르 인코포레이티드	다가 폐렴구균성 다당류-단백질 접합체 조성물
KR101859735B1 (ko) *	2018-02-07	2018-05-21	주식회사 피테크	무통 주사 장치
MX2020008219A (es)	2018-02-08	2020-10-22	Amgen Inc	Formulacion farmaceutica de ph bajo.
NL2020520B1 (en)	2018-03-02	2019-09-12	Labo Bio Medical Invest B V	Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
US12152073B2 (en)	2018-03-14	2024-11-26	Marengo Therapeutics, Inc.	Multifunctional molecules that bind to calreticulin and uses thereof
CA3093509A1 (en)	2018-03-15	2019-09-19	Biontech Rna Pharmaceuticals Gmbh	5'-cap-tri nucleotide- or higher oligonucleotide compounds and their uses in stabilizing rna, expressing proteins and in therapy
CA3093407A1 (en)	2018-03-23	2019-09-26	Bristol-Myers Squibb Company	Antibodies against mica and/or micb and uses thereof
WO2019184920A1 (zh)	2018-03-26	2019-10-03	上海易乐生物技术有限公司	proBDNF调节剂在B细胞相关疾病中的用途
AU2019248547B2 (en)	2018-04-02	2025-07-17	Bristol-Myers Squibb Company	Anti-TREM-1 antibodies and uses thereof
US11673907B2 (en)	2018-04-03	2023-06-13	Revagenix, Inc.	Modular synthesis of aminoglycosides
LT3773713T (lt)	2018-04-06	2025-08-25	Regeneron Pharmaceuticals, Inc.	Leptino receptoriaus agonistinis antikūnas, skirtas kaulų masės didinimui subjektui, kuriam pasireiškia medžiagų apykaitos sutrikimas arba hipoleptinemija
AU2019249255A1 (en)	2018-04-06	2020-11-05	Alastair GARFIELD	Compositions for treating kidney disease
JP2021521182A (ja)	2018-04-12	2021-08-26	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｃｄ７３アンタゴニストとｐｄ−１／ｐｄ−ｌ１軸アンタゴニストの組み合わせ治療
WO2019204462A2 (en)	2018-04-17	2019-10-24	Celldex Therapeutics, Inc.	Anti-cd27 and anti-pd-l1 antibodies and bispecific constructs
WO2019202160A2 (en)	2018-04-20	2019-10-24	Iomx Therapeutics Ag	A 5-thiazolecarboxamide kinase inhibitor and uses thereof
KR102107578B1 (ko) *	2018-05-02	2020-05-07	주식회사 피테크	무통 주사기용 약액주입 제어장치 및 이를 구비하는 무통 주사기
KR102104080B1 (ko) *	2018-05-02	2020-04-23	주식회사 피테크	무통 주사기용 음파발진장치 및 이를 구비하는 무통 주사기
KR101907552B1 (ko) *	2018-05-03	2018-10-12	주식회사 피테크	무바늘 무통 주사 장치
WO2019213384A1 (en)	2018-05-03	2019-11-07	University Of Rochester	Anti-influenza neuraminidase monoclonal antibodies and uses thereof
SG11202011667WA (en)	2018-05-25	2020-12-30	Primmune Therapeutics Inc	Tlr7 agonists
JP7457661B2 (ja)	2018-06-04	2024-03-28	バイオジェン・エムエイ・インコーポレイテッド	低減したエフェクター機能を有する抗ｖｌａ－４抗体
US11951286B2 (en) *	2018-06-12	2024-04-09	Banza Stamping Industry Corp.	Automatic injection device for fluid
GB201809746D0 (en)	2018-06-14	2018-08-01	Berlin Chemie Ag	Pharmaceutical combinations
JP2021527693A (ja)	2018-06-21	2021-10-14	ユマニティセラピューティクス，インコーポレーテッド	神経学的障害の治療及び予防のための組成物及び方法
JP7590185B2 (ja)	2018-06-25	2024-11-26	ダナ－ファーバーキャンサーインスティテュート，インコーポレイテッド	Ｔａｉｒｅファミリーキナーゼインヒビターおよびそれらの使用
ES3004544T3 (en)	2018-06-27	2025-03-12	Bioxcel Therapeutics Inc	Film formulations containing dexmedetomidine and methods of producing them
WO2020010250A2 (en)	2018-07-03	2020-01-09	Elstar Therapeutics, Inc.	Anti-tcr antibody molecules and uses thereof
KR102945860B1 (ko)	2018-07-11	2026-03-31	카 메디컬 리미티드	SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
WO2020018433A1 (en)	2018-07-16	2020-01-23	Kaleo, Inc.	Medicament delivery devices with wireless connectivity and compliance detection
CA3107186A1 (en)	2018-07-30	2020-02-06	Amgen Research (Munich) Gmbh	Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
EP3829642A1 (de)	2018-07-31	2021-06-09	Amgen Inc.	Pharmazeutische formulierungen von maskierten antikörpern
EP3830122A1 (de)	2018-07-31	2021-06-09	Amgen Research (Munich) GmbH	Dosierungsschema für bispezifische bcma-cd3-antikörper
WO2020025792A1 (en)	2018-08-03	2020-02-06	Amgen Research (Munich) Gmbh	Antibody constructs for cldn18.2 and cd3
WO2020029982A1 (en)	2018-08-08	2020-02-13	Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd	Recombinant bifunctional protein targeting cd47 and her2
WO2020047251A1 (en)	2018-08-29	2020-03-05	President And Fellows Of Harvard College	O-glcnac transferase inhibitors and uses thereof
WO2020049208A1 (es)	2018-09-09	2020-03-12	Fundacio Privada Institut De Recerca De La Sida - Caixa	Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida
CA3153959A1 (en)	2018-09-18	2020-03-26	Merrimack Pharmaceuticals, Inc.	Anti-tnfr2 antibodies and uses thereof
WO2020061367A1 (en)	2018-09-19	2020-03-26	Modernatx, Inc.	Compounds and compositions for intracellular delivery of therapeutic agents
WO2020061457A1 (en)	2018-09-20	2020-03-26	Modernatx, Inc.	Preparation of lipid nanoparticles and methods of administration thereof
KR102199724B1 (ko) *	2018-10-05	2021-01-07	주식회사 피테크	무바늘 무통 주사 장치
US11130802B2 (en)	2018-10-10	2021-09-28	Tilos Therapeutics, Inc.	Anti-lap antibody variants
AR117650A1 (es)	2018-10-11	2021-08-18	Amgen Inc	Procesamiento posterior de constructos de anticuerpos biespecíficos
EP3870572B1 (de)	2018-10-23	2026-05-06	Myelopro Diagnostics and Research GmbH	Verbindungen gegen mutiertes calreticulin
DK3643713T3 (da)	2018-10-23	2025-11-03	Iomx Therapeutics Ag	Heterocykliske kinaseinhibitorer og deres anvendelse
US11160791B2 (en)	2018-11-01	2021-11-02	Medefil, Inc.	Dexmedetomidine injection premix formulation in ready to use (RTU) bags
WO2020097627A1 (en)	2018-11-09	2020-05-14	University Of Massachusetts	Anti-cfae antibodies and methods of use
BR112021009111A2 (pt)	2018-11-16	2021-08-24	Bristol-Myers Squibb Company	Anticorpos anti-nkg2a e usos dos mesmos
JP2022513653A (ja)	2018-11-28	2022-02-09	ブリストル－マイヤーズスクイブカンパニー	修飾された重鎖定常領域を含む抗体
MX2021006362A (es)	2018-11-30	2021-10-13	Aleta Biotherapeutics Inc	Anticuerpos de dominio simple contra cll-1.
WO2020118011A1 (en)	2018-12-06	2020-06-11	Alexion Pharmaceuticals, Inc.	Anti-alk2 antibodies and uses thereof
MX2021007394A (es)	2018-12-18	2021-07-15	Regeneron Pharma	Composiciones y metodos para aumentar el peso corporal y la masa muscular magra mediante el uso de antagonistas contra el receptor de leptina, gdf8 y activina a.
TW202039554A (zh)	2018-12-19	2020-11-01	瑞士商諾華公司	抗ＴＮＦ－α抗體
WO2020132378A2 (en)	2018-12-22	2020-06-25	Gliapharm Sa	Compositions and methods of treatment for neurological disorders comprising depression
WO2020140098A1 (en)	2018-12-28	2020-07-02	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 and uses thereof
EP3902584A4 (de)	2018-12-29	2022-09-07	Kaleo, Inc.	Vorrichtungen und verfahren zur abgabe von substanzen in einer vorgefüllten spritze
WO2020144535A1 (en)	2019-01-08	2020-07-16	Aduro Biotech Holdings, Europe B.V.	Methods and compositions for treatment of multiple myeloma
EP3911644A1 (de)	2019-01-16	2021-11-24	Curza Global LLC	Antimikrobielle verbindungen und verfahren
CN113825748A (zh)	2019-01-16	2021-12-21	库扎环球有限责任公司	抗微生物化合物和方法
CN109762067B (zh)	2019-01-17	2020-02-28	北京天广实生物技术股份有限公司	结合人Claudin 18.2的抗体及其用途
BR112021014276A2 (pt)	2019-01-22	2021-09-28	Genentech, Inc.	Anticorpos iga isolados, moléculas de fusão igg-iga isoladas, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, para tratar um indivíduo, para aumentar a expressão de dímeros, trímeros ou tetrâmeros, para aumentar a produção de polímeros, para aumentar a produção de dímeros, para aumentar a produção de um polímero, para diminuir a produção de polímeros, para aumentar a expressão transitória de um anticorpo, para expressar dímeros de moléculas de fusão, para expressar dímeros, trímeros ou tetrâmeros, para purificar um anticorpo, para purificar um estado oligomérico de um anticorpo, composição farmacêutica e uso do anticorpo
EP3914622A1 (de)	2019-01-22	2021-12-01	Bristol-Myers Squibb Company	Antikörper gegen il-7r-alpha-untereinheit und deren verwendungen
EP4272825A3 (de)	2019-01-22	2023-12-06	Aeovian Pharmaceuticals, Inc.	Mtorc-1-modulatoren und verwendungen davon
MX2021009245A (es)	2019-01-31	2021-11-12	Modernatx Inc	Metodos de preparacion de nanoparticulas lipidicas.
WO2020168466A1 (en)	2019-02-19	2020-08-27	Stemirna Therapeutics Co., Ltd.	Modified nucleoside and synthetic methods thereof
AU2020226893B2 (en)	2019-02-21	2025-02-27	Marengo Therapeutics, Inc.	Multifunctional molecules that bind to T cell related cancer cells and uses thereof
GB2597851B (en)	2019-02-21	2024-05-29	Marengo Therapeutics Inc	Antibody molecules that bind to NKP30 and uses thereof
CA3131953A1 (en)	2019-03-01	2020-09-10	Merrimack Pharmaceuticals, Inc.	Anti-tnfr2 antibodies and uses thereof
US10570210B1 (en)	2019-03-04	2020-02-25	Beijing Mabworks Biotech Co.Ltd	Antibodies binding CD40 and uses thereof
CN113661179A (zh)	2019-03-11	2021-11-16	比奥根Ma公司	含有抗lingo-1抗体的药物组合物
CA3132521A1 (en)	2019-03-25	2020-10-01	Visterra, Inc.	Compositions and methods for treating and preventing influenza
CN113993896A (zh)	2019-04-08	2022-01-28	比奥根Ma公司	抗整联蛋白抗体及其用途
US12404331B2 (en)	2019-04-19	2025-09-02	Tcrcure Biopharma Corp.	Anti-PD-1 antibodies and uses thereof
WO2020237081A1 (en)	2019-05-21	2020-11-26	Bristol-Myers Squibb Company	Immunomodulators
BR112021023335A2 (pt)	2019-06-11	2022-01-04	Regeneron Pharma	Anticorpos recombinante isolado ou seu fragmento de ligação ao antígeno e monoclonal isolado ou seu fragmento de ligação ao antígeno, composição farmacêutica, molécula polinucleotídica isolada, vetor, célula, método de diminuição do risco de adquirir infecção por p. aeruginosa, e, métodos de diminuição da carga bacteriana em um sujeito com uma infecção por p. aeruginosa, de aumento da sobrevida ou da probabilidade de sobrevida de um sujeito que sofre de infecção por p. aeruginosa ou de um sujeito que corre risco de infecção por p. aeruginosa, para melhorar ou reduzir a gravidade, a duração ou a frequência de ocorrência de pelo menos um sintoma de uma infecção por p. aeruginosa, para aumentar a sobrevida ou a probabilidade de sobrevida de um sujeito que sofre de fibrose cística
AU2020290573B2 (en)	2019-06-13	2026-01-29	Amgen Inc.	Automated biomass-based perfusion control in the manufacturing of biologics
SG11202112762TA (en)	2019-07-08	2021-12-30	Amgen Inc	Multispecific transthyretin immunoglobulin fusions
CN114375310A (zh)	2019-07-11	2022-04-19	卡尔医学有限公司	数个异二聚体及其数个使用方法
EP3999539A1 (de)	2019-07-15	2022-05-25	Intervet International B.V.	Caninisierte antikörper gegen humanes und canines ctla-4
CN114144435B (zh)	2019-07-15	2024-06-25	百时美施贵宝公司	针对人trem-1的抗体及其用途
CA3145345A1 (en)	2019-07-15	2021-01-21	Intervet International B.V.	Caninized antibodies against canine ctla-4
EP3999543A1 (de)	2019-07-15	2022-05-25	Bristol-Myers Squibb Company	Anti-trem-1-antikörper und verwendungen davon
US20240024288A1 (en)	2019-07-19	2024-01-25	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens
JP2022543773A (ja)	2019-07-31	2022-10-14	モデルナティエックスインコーポレイテッド	免疫細胞へのｒｎａ干渉剤の送達のための組成物及び方法
PH12022550110A1 (en)	2019-07-31	2022-12-12	Sk Bioscience Co Ltd	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US11167087B2 (en) *	2019-08-09	2021-11-09	Kaleo, Inc.	Devices and methods for delivery of substances within a prefilled syringe
UY38836A (es)	2019-08-13	2021-02-26	Amgen Inc	Muteínas de interleucina-2 para la expansión de células t reguladoras
KR20220079857A (ko)	2019-09-13	2022-06-14	루트거스, 더 스테이트 유니버시티 오브 뉴 저지	Aav-상용성 라미닌-링커 중합 단백질
WO2021087056A1 (en)	2019-10-30	2021-05-06	Bristol-Myers Squibb Company	Immunomodulators
SI3819007T1 (sl)	2019-11-11	2024-10-30	Amgen Inc.	Režim odmerjanja sredstev proti BCMA
CA3156683A1 (en)	2019-11-13	2021-05-20	Amgen Inc.	Method for reduced aggregate formation in downstream processing of bispecific antigen-binding molecules
AU2020384885A1 (en)	2019-11-13	2022-06-09	Curza Global, Llc	Antimicrobial compounds and methods
ES2970395T3 (es)	2019-11-19	2024-05-28	Bristol Myers Squibb Co	Péptidos macrocíclicos como inhibidores de PD-L1 e inmunomoduladores para el tratamiento de cáncer y enfermedades infecciosas
WO2021119467A1 (en)	2019-12-11	2021-06-17	Visterra, Inc.	Compositions and methods for treating and preventing influenza
CN114867749A (zh)	2019-12-17	2022-08-05	安进公司	用于疗法中的双重白介素-2/tnf受体激动剂
MX2022007677A (es)	2019-12-20	2022-07-19	Intervet Int Bv	Anticuerpos para receptor alfa de interleucina-4 canino.
JP2023507323A (ja)	2019-12-20	2023-02-22	アムジエン・インコーポレーテツド	固形腫瘍の治療のためのメソセリン標的化ｃｄ４０アゴニスト多重特異性抗体コンストラクト
AU2020407124A1 (en)	2019-12-20	2022-07-21	Momenta Pharmaceuticals, Inc.	Antibodies against integrin alpha 11 beta 1
CN114829396A (zh)	2019-12-20	2022-07-29	英特维特国际股份有限公司	用于治疗特应性皮炎的双特异性犬源化抗体和双特异性结合伴体
WO2021136308A1 (en)	2020-01-03	2021-07-08	Biosion Inc.	Antibodies binding bcma and uses thereof
AU2020416273A1 (en)	2020-01-03	2022-07-28	Marengo Therapeutics, Inc.	Anti-TCR antibody molecules and uses thereof
JP2023510737A (ja)	2020-01-06	2023-03-15	ブリストル－マイヤーズスクイブカンパニー	免疫調節剤
CN114929714B (zh)	2020-01-06	2024-05-31	百时美施贵宝公司	用于治疗癌症和感染性疾病的作为pd-l1抑制剂和免疫调节剂的大环肽
CN110818795B (zh)	2020-01-10	2020-04-24	上海复宏汉霖生物技术股份有限公司	抗tigit抗体和使用方法
WO2021150824A1 (en)	2020-01-22	2021-07-29	Amgen Research (Munich) Gmbh	Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
CN116133652A (zh)	2020-01-31	2023-05-16	摩登纳特斯有限公司	制备脂质纳米粒子的方法
BR112022017174A2 (pt)	2020-02-27	2022-10-18	Chia Tai Tianqing Pharmaceutical Group Co Ltd	Anticorpo monoclonal isolado, ou uma porção de ligação ao antígeno do mesmo, nucleotídeo, vetor de expressão, célula hospedeira, composição farmacêutica e métodos de tratamento de uma doença alérgica e de um tumor
WO2021173965A1 (en)	2020-02-28	2021-09-02	Massachusetts Institute Of Technology	Identification of variable influenza residues and uses thereof
EP4118118A1 (de)	2020-03-09	2023-01-18	Bristol-Myers Squibb Company	Antikörper gegen cd40 mit verbesserter agonistenaktivität
CN115485288A (zh)	2020-03-16	2022-12-16	百时美施贵宝公司	免疫调节剂
MX2022011632A (es)	2020-03-19	2022-10-13	Amgen Inc	Anticuerpos contra mucina 17 y usos de los mismos.
WO2021195089A1 (en)	2020-03-23	2021-09-30	Sorrento Therapeutics, Inc.	Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof
KR20220161407A (ko)	2020-03-30	2022-12-06	브리스톨-마이어스 스큅 컴퍼니	면역조정제
CA3170570A1 (en)	2020-04-01	2021-10-07	James J. KOBIE	Monoclonal antibodies against the hemagglutinin (ha) and neuraminidase (na) of influenza h3n2 viruses
US20230272056A1 (en)	2020-04-09	2023-08-31	Merck Sharp & Dohme Llc	Affinity matured anti-lap antibodies and uses thereof
WO2021216488A1 (en)	2020-04-21	2021-10-28	Regeneron Pharmaceuticals, Inc.	Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof
EP3901151B1 (de)	2020-04-21	2026-04-01	iOmx Therapeutics AG	Halogenierte heteroaryl- und andere heterocyclische kinaseinhibitoren und verwendungen davon
AU2021262482A1 (en)	2020-04-28	2023-01-05	Iomx Therapeutics Ag	Bicyclic kinase inhibitors and uses thereof
KR20230002261A (ko)	2020-04-28	2023-01-05	더 락커펠러 유니버시티	항-sars-cov-2 중화 항체 및 이의 사용 방법
JP2023524445A (ja)	2020-04-29	2023-06-12	アムジェンインコーポレイテッド	医薬製剤
EP4142790A1 (de)	2020-04-29	2023-03-08	Amgen Inc.	Pharmazeutische formulierung
IL297806A (en)	2020-04-30	2022-12-01	Sairopa B V	Anti-cd103 antibodies
CN115916340A (zh)	2020-05-08	2023-04-04	百时美施贵宝公司	免疫调节剂
WO2021231729A1 (en)	2020-05-13	2021-11-18	Sanofi	Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
WO2021231732A1 (en)	2020-05-15	2021-11-18	Bristol-Myers Squibb Company	Antibodies to garp
US12312412B2 (en)	2020-05-19	2025-05-27	Amgen Inc.	MAGEB2 binding constructs
US20230277524A1 (en)	2020-05-22	2023-09-07	Trailhead Biosystems Inc.	Combination therapy for treatment of viral infections
CN111529830B (zh) *	2020-05-22	2024-10-15	江阴市机电技术有限公司	一种启动稳定的给药装置
AU2021281554A1 (en)	2020-05-29	2022-12-15	Amgen Inc.	Adverse effects-mitigating administration of a bispecific antibody construct binding to CD33 and CD3
WO2021252708A1 (en)	2020-06-11	2021-12-16	President And Fellows Of Harvard College	Stabilized trioxacarcin antibody drug conjugates and uses thereof
FR3112939B1 (fr)	2020-07-31	2024-01-05	Univ Montpellier	Produit universel de thérapie cellulaire et son utilisation
AU2021320333A1 (en)	2020-08-07	2023-03-30	Fortis Therapeutics, Inc.	Immunoconjugates targeting CD46 and methods of use thereof
EP4200333A1 (de)	2020-08-24	2023-06-28	Amgen Inc.	Pharmazeutische formulierung mit einem biss, bispezifischem antikörper und methionin
US20220088323A1 (en) *	2020-09-21	2022-03-24	Boston Scientific Scimed, Inc.	Fluid pressure indicators for medical devices
JP2023544730A (ja)	2020-10-02	2023-10-25	ブリストル－マイヤーズスクイブカンパニー	大環状ペプチドボロネート免疫調節剤
ES2989813T3 (es)	2020-10-08	2024-11-27	Bristol Myers Squibb Co	Inmunomoduladores MILLA diméricos
KR20230084211A (ko)	2020-10-09	2023-06-12	브리스톨-마이어스 스큅 컴퍼니	마크로시클릭 면역조정제
TW202228775A (zh)	2020-10-14	2022-08-01	美商維里迪恩醫療股份有限公司	用於治療甲狀腺眼病之組合物及方法
US20240002518A1 (en)	2020-10-15	2024-01-04	Intervet Inc.	Caninized rat antibodies to canine interleukin-31 receptor alpha
CN116710116A (zh)	2020-10-30	2023-09-05	Ｘｅｎｏ－Ｉｎｔｅｒｆａｃｅ株式会社	β折叠股桥肽
WO2022092294A1 (ja)	2020-10-30	2022-05-05	学校法人慶應義塾	サルコペニア関連疾患等の新規治療および予防
EP4240758A1 (de)	2020-11-04	2023-09-13	The Rockefeller University	Neutralisierende anti-sars-cov-2-antikörper
MX2023005323A (es)	2020-11-06	2023-05-19	Amgen Inc	Construcciones polipeptidicas que se unen a cd3.
CA3200317A1 (en)	2020-11-06	2022-05-12	Amgen Inc.	Multitargeting bispecific antigen-binding molecules of increased selectivity
KR20230098335A (ko)	2020-11-06	2023-07-03	암젠 인크	클리핑 비율이 감소된 항원 결합 도메인
AU2021374036A1 (en)	2020-11-06	2023-06-08	Amgen Inc.	Polypeptide constructs selectively binding to cldn6 and cd3
TW202233682A (zh)	2020-11-10	2022-09-01	美商安進公司	用於投與ＢＣＭＡｘＣＤ３結合分子之方法
CA3197951A1 (en)	2020-11-11	2022-05-19	Ugur Sahin	Monoclonal antibodies directed against programmed death-1 protein and their use in medicine
WO2022116877A1 (en)	2020-12-02	2022-06-09	Shanghai Henlius Biotech, Inc.	ANTI-GARP/TGFβ ANTIBODIES AND METHODS OF USE
AR124267A1 (es)	2020-12-09	2023-03-01	Genentech Inc	Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
DE102020134181A1 (de)	2020-12-18	2022-06-23	Henke-Sass, Wolf Gmbh	Vorrichtung zum Applizieren eines Fluids
CN114685669A (zh)	2020-12-30	2022-07-01	和铂医药(苏州)有限公司	结合trop2的抗体及其用途
EP4277926A1 (de)	2021-01-15	2023-11-22	The Rockefeller University	Neutralisierende anti-sars-cov-2-antikörper
US12268847B1 (en)	2021-02-10	2025-04-08	Kaleo, Inc.	Devices and methods for delivery of substances within a medicament container
US12433847B2 (en)	2021-03-09	2025-10-07	Massachusetts Institute Of Technology	Branched poly(-amino esters) for the delivery of nucleic acids
IL305572A (en)	2021-03-12	2023-10-01	Bristol Myers Squibb Co	KRAS inhibitors
CN117157306A (zh)	2021-03-24	2023-12-01	百时美施贵宝公司	免疫调节剂
EP4320159A1 (de)	2021-04-09	2024-02-14	Celldex Therapeutics, Inc.	Antikörper gegen ilt4, bispezifische anti-ilt4/pd-l1-antikörper und verwendungen davon
WO2022221284A2 (en)	2021-04-12	2022-10-20	Bristol-Myers Squibb Company	Cyclic peptide immunomodulators
WO2022234102A1 (en)	2021-05-06	2022-11-10	Amgen Research (Munich) Gmbh	Cd20 and cd22 targeting antigen-binding molecules for use in proliferative diseases
US20240207354A1 (en)	2021-05-06	2024-06-27	Amgen Inc.	Etelcalcetide formulations
US20240218057A1 (en)	2021-05-06	2024-07-04	The Rockefeller University	Neutralizing anti- sars-cov-2 antibodies and methods of use thereof
US20240316006A1 (en)	2021-05-10	2024-09-26	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Pharmaceutical compositions for treating neurological conditions
EP4340879A4 (de)	2021-05-20	2025-03-26	Dianthus Therapeutics OpCo, Inc.	An c1s bindende antikörper und verwendungen davon
MX2023013574A (es)	2021-05-26	2024-02-12	Oxford Biotherapeutics Ltd	Combinacion farmaceutica que comprende un anticuerpo anti-cd205 y un inhibidor del punto de control.
TW202313065A (zh)	2021-05-28	2023-04-01	美商季卡尼醫療公司	用於治療遺傳疾病之化合物
WO2022258792A1 (en)	2021-06-09	2022-12-15	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Novel anti-fibrotic drugs
EP4352077A1 (de)	2021-06-09	2024-04-17	Bristol-Myers Squibb Company	Zyklische peptidimmunmodulatoren
CA3220933A1 (en)	2021-06-30	2023-01-05	Amgen Inc.	Method of reconstituting lyophilized formulation
EP4370530A1 (de)	2021-07-12	2024-05-22	Bristol-Myers Squibb Company	Makrocyclische immunomodulatoren
WO2023004240A1 (en)	2021-07-19	2023-01-26	Bristol-Myers Squibb Company	Macrocylic immunomodulators
WO2023004344A1 (en)	2021-07-20	2023-01-26	Regeneron Pharmaceuticals, Inc.	Butyrophilin-like 2 for treating inflammatory disorders
CN113398365B (zh) *	2021-07-21	2022-10-28	南京瑞淇卓越医疗美容诊所有限公司	一种心血管内科用的临床造影注射装置及注射方法
TW202320850A (zh)	2021-08-10	2023-06-01	美商維里迪恩醫療股份有限公司	用於治療甲狀腺眼病之組合物、劑量及方法
EP4384534A1 (de)	2021-08-11	2024-06-19	Sanofi Pasteur, Inc.	Verkürzte influenza-neuraminidase und verfahren zur verwendung davon
WO2023021169A1 (en)	2021-08-20	2023-02-23	Intervet International B.V.	Antibodies and igg fusion proteins with an extended half-life
US20240368249A1 (en)	2021-08-20	2024-11-07	Intervet Inc.	Fusion proteins for treating atopic dermatitis
WO2023039108A1 (en)	2021-09-08	2023-03-16	Affinivax, Inc.	Coronavirus vaccine
CN113773401B (zh)	2021-09-15	2023-06-20	宜明昂科生物医药技术（上海）股份有限公司	靶向cd47和pd-l1的重组融合蛋白及其制备和用途
EP4408468A4 (de)	2021-09-28	2025-07-02	Frontaim Biomedicines Inc	Mehrere formate molekularer komplexe
AU2022361432A1 (en)	2021-10-08	2024-05-23	Sanofi Pasteur Inc.	Multivalent influenza vaccines
CN113754769B (zh)	2021-10-13	2023-06-06	宜明昂科生物医药技术（上海）股份有限公司	靶向cd70的抗体及其制备和用途
CN113956363B (zh)	2021-10-13	2023-03-31	宜明昂科生物医药技术（上海）股份有限公司	靶向cd47和cd24的重组融合蛋白及其制备和用途
CN113831412B (zh)	2021-10-13	2023-06-20	宜明昂科生物医药技术（上海）股份有限公司	靶向cd24的抗体及其制备和用途
CA3234995A1 (en)	2021-10-14	2023-04-20	Latticon (Suzhou) Biopharmaceuticals Co., Ltd.	Novel antibody-cytokine fusion protein, preparation method therefor and use thereof
CN118159549A (zh)	2021-10-20	2024-06-07	百时美施贵宝公司	免疫调节剂
JP2024543822A (ja)	2021-11-03	2024-11-26	アフィメドゲーエムベーハー	二重特異性ｃｄ１６ａバインダー
AU2022381918A1 (en)	2021-11-03	2024-06-13	Affimed Gmbh	Bispecific cd16a binders
CA3237134A1 (en)	2021-11-05	2023-05-11	Timothy ALEFANTIS	Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
CA3237139A1 (en)	2021-11-05	2023-05-11	Sanofi	Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
WO2023077521A1 (en)	2021-11-08	2023-05-11	Celldex Therapeutics, Inc	Anti-ilt4 and anti-pd-1 bispecific constructs
WO2023089314A1 (en)	2021-11-18	2023-05-25	Oxford Biotherapeutics Limited	Pharmaceutical combinations
WO2023096904A2 (en)	2021-11-24	2023-06-01	President And Fellows Of Harvard College	C-16 modified trioxacarcins, antibody drug conjugates, and uses thereof
WO2023102507A1 (en)	2021-12-03	2023-06-08	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
US12171779B2 (en)	2021-12-08	2024-12-24	University Of South Florida	Regulated drug delivery via controlled degradable chondroitin sulfate particles
WO2023105281A1 (en)	2021-12-11	2023-06-15	Fundaciò Privada Institut De Recerca De La Sida-Caixa	Soluble tigit recombinant proteins
JP2024546914A (ja)	2021-12-15	2024-12-26	インテリウス・バイオセラピューティクス・インコーポレイテッド	偽型ウイルス粒子、それを含む組成物、及びそれらの使用
WO2023111157A1 (en)	2021-12-16	2023-06-22	Intervet International B.V.	Caninized and felinized antibodies to human ngf
US20250049728A1 (en)	2021-12-16	2025-02-13	Modernatx, Inc.	Processes for preparing lipid nanoparticles
JP2024546759A (ja)	2021-12-16	2024-12-26	インターベットインターナショナルベー．フェー．	イヌインターロイキン－３１受容体アルファｉｉに対するイヌ化抗体
AU2022408865A1 (en)	2021-12-17	2024-07-04	Shanghai Henlius Biologics Co., Ltd.	Anti-ox40 antibodies, multispecific antibodies and methods of use
JP2025501522A (ja)	2021-12-17	2025-01-22	シャンハイ・ヘンリウス・バイオテック・インコーポレイテッド	抗ｏｘ４０抗体及び使用方法
CN118786118A (zh)	2021-12-30	2024-10-15	库扎环球有限责任公司	抗微生物化合物和方法
CN118973613A (zh)	2022-01-25	2024-11-15	早野元词	抑制包括肌肉减少症的与衰老相关的异常的新型治疗与预防
EP4469159A1 (de)	2022-01-27	2024-12-04	The Rockefeller University	Breit neutralisierende anti-sars-cov-2-antikörper gegen die n-terminale domäne des spike-proteins und verfahren zur verwendung davon
WO2023144206A1 (en)	2022-01-27	2023-08-03	Sanofi Pasteur	Modified vero cells and methods of using the same for virus production
IL315208A (en)	2022-02-24	2024-10-01	Sinomab Bioscience Ltd	Bispecific binding proteins against alarmins and uses thereof
CA3245419A1 (en)	2022-03-04	2023-09-07	Revagenix, Inc.	Broad-spectrum aminoglycosides and their uses
CN119137665A (zh)	2022-03-14	2024-12-13	赛诺菲巴斯德有限公司	用于疫苗产生的蛋白质设计中的机器学习技术
WO2023173393A1 (zh)	2022-03-18	2023-09-21	北京天广实生物技术股份有限公司	结合b7-h3的抗体及其用途
WO2023175171A1 (en)	2022-03-18	2023-09-21	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Bk polyomavirus antibodies and uses thereof
CN118974096A (zh)	2022-03-25	2024-11-15	上海复宏汉霖生物技术股份有限公司	抗msln抗体及使用方法
JP2025511189A (ja)	2022-03-28	2025-04-15	ブリストル－マイヤーズスクイブカンパニー	大環状免疫調節剤
WO2023193002A1 (en)	2022-04-01	2023-10-05	Modernatx, Inc.	Cross mixers for lipid nanoparticle production, and methods of operating the same
EP4257132A1 (de)	2022-04-08	2023-10-11	iOmx Therapeutics AG	Sik3-inhibitoren zum behandeln von krankheiten, die gegen death-rezeptor -signaltransduktion resistent sind
EP4257609A1 (de)	2022-04-08	2023-10-11	iOmx Therapeutics AG	Kombinationstherapien basierend auf pd-1-inhibitoren und sik3-inhibitoren
CA3256382A1 (en)	2022-04-26	2023-11-02	Amgen Inc.	FREEZE DRYING PROCESS
IL316597A (en)	2022-05-12	2024-12-01	Amgen Res Munich Gmbh	Multi-chain, multi-purpose, bispecific antigen-binding compounds with enhanced sensitivity
US11932693B2 (en)	2022-05-12	2024-03-19	BioNTech SE	Monoclonal antibodies directed against programmed death-1 protein and their use in medicine
GB202207263D0 (en)	2022-05-18	2022-06-29	Annexin Pharmaceuticals Ab	Therapeutic compositions
EP4526323A1 (de)	2022-05-20	2025-03-26	Bristol-Myers Squibb Company	Makrocyclische immunomodulatoren
CN117186238A (zh)	2022-05-31	2023-12-08	宜明昂科生物医药技术（上海）股份有限公司	靶向pd-l1和vegf的重组融合蛋白及其制备和用途
WO2023235380A1 (en)	2022-06-01	2023-12-07	Zikani Therapeutics, Inc.	Macrolides for treating genetic diseases
KR20250022140A (ko)	2022-06-10	2025-02-14	브리스톨-마이어스 스큅 컴퍼니	Kras 억제제로서의 테트라하이드로피리도 3,4-d 피리미딘 유도체
KR20250022142A (ko)	2022-06-10	2025-02-14	브리스톨-마이어스 스큅 컴퍼니	Kras 억제제로서의 피리도[4,3-d]피리미딘 유도체
WO2023250513A1 (en)	2022-06-24	2023-12-28	Zikani Therapeutics, Inc.	13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
CA3262768A1 (en)	2022-07-25	2024-02-01	Interius Biotherapeutics, Inc.	Mutated polypeptides, compositions containing them, and their uses
WO2024026475A1 (en)	2022-07-29	2024-02-01	Modernatx, Inc.	Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
WO2024026487A1 (en)	2022-07-29	2024-02-01	Modernatx, Inc.	Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
EP4561546A1 (de)	2022-07-29	2025-06-04	ModernaTX, Inc.	Lipidnanopartikelzusammensetzungen mit oberflächenlipidderivaten und zugehörige verwendungen
WO2024036270A1 (en)	2022-08-11	2024-02-15	Bristol-Myers Squibb Company	Kras inhibitors
IL318420A (en)	2022-08-16	2025-03-01	Bristol Myers Squibb Co	Kras inhibitors
KR20250053926A (ko)	2022-09-01	2025-04-22	지카니 테라퓨틱스, 인크.	13-원 마크롤리드를 사용한 가족성 선종성 폴립증의 치료
JP2025530170A (ja)	2022-09-07	2025-09-11	ブリストル－マイヤーズスクイブカンパニー	Ｋｒａｓｇ１２ｄ阻害剤
WO2024059472A1 (en)	2022-09-12	2024-03-21	Bristol-Myers Squibb Company	Macrocyclic immunomodulators
JP2025533434A (ja)	2022-09-14	2025-10-07	アムジエン・インコーポレーテツド	二重特異性分子安定化組成物
WO2024091918A2 (en)	2022-10-25	2024-05-02	Modernatx, Inc.	Methods of lipid nanoparticle production in cross-mixers
AU2023385709A1 (en)	2022-11-21	2025-06-12	Dianthus Therapeutics Opco, Inc.	Antibodies that bind to c1s and uses thereof
CN115737992B (zh) *	2022-11-24	2024-06-07	深圳市本尚医疗科技有限公司	无针注射器
WO2024115713A1 (en)	2022-11-30	2024-06-06	The Trustees Of The University Of Pennsylvania	Brisc deubiquitinating enzyme inhibitors
WO2024121380A1 (en)	2022-12-08	2024-06-13	Pierre Fabre Medicament	Vaccinal composition and adjuvant
GB202219154D0 (en)	2022-12-19	2023-02-01	Metacurum Biotech Ab	Antibodies and uses thereof
US11806334B1 (en)	2023-01-12	2023-11-07	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens
WO2024163477A1 (en)	2023-01-31	2024-08-08	University Of Rochester	Immune checkpoint blockade therapy for treating staphylococcus aureus infections
CN121002060A (zh)	2023-02-13	2025-11-21	英特维特国际股份有限公司	犬il-13的犬抗体
EP4665756A1 (de)	2023-02-13	2025-12-24	Intervet International B.V.	Antikörper gegen hunde-il-4
CN121219315A (zh)	2023-03-03	2025-12-26	塞德斯医疗公司	抗干细胞因子(scf)和抗胸腺基质淋巴细胞生成素(tslp)抗体及双特异性构建体
WO2024187062A1 (en)	2023-03-08	2024-09-12	Amgen Inc.	Controlled-ice nucleation lyophilization process for bispecific molecules
EP4680344A1 (de)	2023-03-16	2026-01-21	Inmagene Pte. Ltd.	Auf ilt7 gerichtete antikörper und verwendungen davon
AU2024251934A1 (en)	2023-04-12	2025-10-30	Shanghai Kangabio Co., Limited	Multifunctional molecules comprising masked interleukin 12 and methods of use
JP2026512759A (ja)	2023-04-21	2026-04-20	ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー	フェロトーシス阻害剤
WO2024229176A1 (en)	2023-05-04	2024-11-07	Affinivax, Inc.	Rhizavidin variants
KR20260012768A (ko)	2023-05-18	2026-01-27	어넥신 파마큐티컬스 아베	황반 부종 또는 망막 정맥 폐쇄 치료에서 사용하기 위한 항-vegf 작용제와의 병용 요법으로서의 아넥신 a5 단백질
WO2024240260A1 (zh)	2023-05-24	2024-11-28	南京金斯瑞生物科技有限公司	用于制备环状rna的载体和方法
CN121620357A (zh)	2023-06-01	2026-03-06	赛诺菲巴斯德有限公司	包含mRNA脂质纳米颗粒的热稳定组合物
WO2024251240A1 (zh)	2023-06-09	2024-12-12	徕特康(苏州)生物制药有限公司	抗her2互补性双特异抗体-药物偶联物及其制备方法和用途
AU2024305430A1 (en)	2023-06-12	2026-01-22	Nanjing Probio Biotech Co., Ltd.	Antibody binding to human ccr8 and the use thereof
MX2025014635A (es)	2023-06-14	2026-02-03	Amgen Inc	Moleculas captadoras de enmascaramiento de celulas t
WO2024259373A1 (en)	2023-06-14	2024-12-19	Modernatx, Inc.	Compounds and compositions for delivery of therapeutic agents
TW202504599A (zh)	2023-06-30	2025-02-01	美商必治妥美雅史谷比公司	Kras抑制劑
TW202509078A (zh)	2023-07-07	2025-03-01	美商維里迪恩醫療股份有限公司	治療慢性甲狀腺眼病之方法
WO2025046492A1 (en)	2023-08-31	2025-03-06	Revagenix, Inc.	Broad spectrum aminoglycosides and uses thereof
WO2025051975A1 (en)	2023-09-06	2025-03-13	Sanofi	Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
IL326876A (en)	2023-09-06	2026-04-01	Viridian Therapeutics Inc	Pharmaceutical preparations of anti-IGF-1R antibodies
WO2025082594A1 (en)	2023-10-17	2025-04-24	BioNTech SE	Antigen binding proteins specifically binding to cd3 and their use in medicine
WO2025083076A1 (en)	2023-10-17	2025-04-24	BioNTech SE	Antigen binding proteins specifically binding to cd3 and their use in medicine
WO2025122619A1 (en)	2023-12-06	2025-06-12	Bristol-Myers Squibb Company	Kras g12c inhibitors
WO2025136985A1 (en)	2023-12-17	2025-06-26	Viridian Therapeutics, Inc.	Compositions, doses, and methods for treatment of thyroid eye disease
WO2025151502A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Modified antibodies
WO2025151496A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Compositions and methods for treatment of thyroid eye disease
WO2025151492A1 (en)	2024-01-09	2025-07-17	Viridian Therapeutics, Inc.	Compositions and methods for treatment of thyroid eye disease
WO2025157389A1 (en)	2024-01-22	2025-07-31	Iomx Therapeutics Ag	Combinations of halogenated heterocyclic kinase inhibitors and vegfr inhibitors
WO2025160127A1 (en)	2024-01-23	2025-07-31	Modernatx, Inc.	Ionizable lipids and compositions thereof for delivery of therapeutic agents
WO2025160381A1 (en)	2024-01-26	2025-07-31	Modernatx, Inc.	Methods of preparing lipid nanoparticles
WO2025166202A1 (en)	2024-01-31	2025-08-07	Modernatx, Inc.	Lipid nanoparticle compositions comprising sialic acid derivatives and the uses thereof
WO2025168716A1 (en)	2024-02-07	2025-08-14	Eyebiotech Limited	Compositions, doses, and methods for treatment of ocular diseases
WO2025188845A1 (en)	2024-03-05	2025-09-12	Zenas Biopharma, Inc.	STABLE FORMULATIONS FOR TNFα ANTIBODIES AND USES THEREOF
WO2025193583A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193574A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193571A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193573A1 (en)	2024-03-11	2025-09-18	Bristol-Myers Squibb Company	Macrocyclic peptides useful as immunomodulators
WO2025193903A1 (en)	2024-03-15	2025-09-18	Affinivax, Inc.	Pneumococcal polysaccharide compositions and uses thereof
WO2025229127A1 (en)	2024-04-30	2025-11-06	Iomx Therapeutics Ag	A halogenated-heteroaryl kinase inhibitor for treating soft tissue sarcoma and vascular tumors
EP4643861A1 (de)	2024-04-30	2025-11-05	iOmx Therapeutics AG	Halogenierter heteroarylkinasehemmer zur behandlung von weichgewebesarkom und gefässtumoren
EP4653460A1 (de)	2024-05-23	2025-11-26	Egle Therapeutics	Il18r-agonist-antikörper und verwendungen davon
WO2025242910A1 (en)	2024-05-23	2025-11-27	Egle Therapeutics	Il18r agonist antibodies and uses thereof
WO2025257588A1 (en)	2024-06-10	2025-12-18	Affimed Gmbh	Cd16a/tumor antigen polyspecific binder for use in the treatment of immune checkpoint inhibitor resistance
EP4670733A1 (de)	2024-06-27	2025-12-31	Sanofi	Verfahren zur herstellung von viralen proteinen und deren verwendungen
WO2026027944A1 (en)	2024-07-30	2026-02-05	Sairopa B.V.	Anti-sirp alpha antibody formulations and uses thereof
WO2026027730A1 (en)	2024-07-31	2026-02-05	Sanofi	Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
WO2026039512A1 (en)	2024-08-14	2026-02-19	Bristol-Myers Squibb Company	Kras inhibitors
WO2026044176A1 (en)	2024-08-23	2026-02-26	University Of Massachusetts	Anti-etec adhesin protein antibodies and methods of use
WO2026052773A1 (en)	2024-09-06	2026-03-12	Sanofi	Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
WO2026064599A1 (en)	2024-09-19	2026-03-26	Zenas Biopharma, Inc.	Stable formulations for ctla4-ig fusion proteins and uses thereof
WO2026087751A1 (en)	2024-10-24	2026-04-30	Affimed Gmbh	Combination of immune cell engager and nk cell products

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2704543A (en) *		1955-03-22		Hypo jet injector
US2101140A (en) *	1935-03-23	1937-12-07	Raymond W Hege	Automatic injecting syringe device
US2380534A (en) *	1941-04-26	1945-07-31	Marshall L Lockhart	Hypodermic injector
US2605763A (en) *	1948-01-31	1952-08-05	Becton Dickinson Co	Injection device
US2547099A (en) *	1948-03-11	1951-04-03	Becton Dickinson Co	Injection device and ampoule
US2680439A (en) *	1948-09-08	1954-06-08	Arnold K Sutermeister	High-pressure injection device
US2670121A (en) *	1951-01-31	1954-02-23	Scherer Corp R P	Flexible follower for metal ampoules
US2816543A (en) *	1954-07-12	1957-12-17	Scherer Corp R P	Hypodermic injector
NL268186A (de) *	1960-08-15
US3292621A (en) *	1963-07-19	1966-12-20	Oscar H Banker	Jet type protable inoculator
US3292622A (en) *	1964-09-21	1966-12-20	Oscar H Banker	Power operated inoculator
US3424154A (en) *	1965-11-08	1969-01-28	Charles W Kinsley	Injection system
US3561443A (en) *	1968-09-06	1971-02-09	Oscar H Banker	Inoculator gun with delayed action
US3688765A (en) *	1969-10-03	1972-09-05	Jack S Gasaway	Hypodermic injection device
US3945379A (en) *	1974-08-08	1976-03-23	Smithkline Corporation	Injection device
JPS51130094A (en) *	1975-05-08	1976-11-12	Asahi Chemical Ind	Twoostage pressure injector
CA1178503A (en) *	1982-05-27	1984-11-27	Health-Mor Personal Care Corporation	Needleless hypodermic injector
HU186718B (en) *	1983-06-29	1985-09-30	Radelkis Electrokemiai	Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin
US4596556A (en) *	1985-03-25	1986-06-24	Bioject, Inc.	Hypodermic injection apparatus
US4680027A (en) *	1985-12-12	1987-07-14	Injet Medical Products, Inc.	Needleless hypodermic injection device
EP0250022A3 (de) *	1986-06-17	1988-06-22	SICIM SpA	Tragbarer hypodermatischer Injektor
US4722728A (en) *	1987-01-23	1988-02-02	Patents Unlimited, Ltd.	Needleless hypodermic injector
US4790824A (en) *	1987-06-19	1988-12-13	Bioject, Inc.	Non-invasive hypodermic injection device
US4940460A (en) *	1987-06-19	1990-07-10	Bioject, Inc.	Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) *	1987-06-19	1990-07-17	Bioject, Inc.	Pre-filled ampule and non-invasive hypodermic injection device assembly
DE3814023A1 (de) *	1987-07-13	1989-01-26	Medizin Labortechnik Veb K	Injektionsvorrichtung mit medikamentendepot
US5009637A (en) *	1987-11-16	1991-04-23	Sy-Quest International Limited	Apparatus for hypodermic injection of liquids
US5073165A (en) *	1988-02-05	1991-12-17	Marpam International, Inc.	Hypodermic jet injector and cartridge therefor
US4913699A (en) *	1988-03-14	1990-04-03	Parsons James S	Disposable needleless injection system
US5024656A (en) *	1988-08-30	1991-06-18	Injet Medical Products, Inc.	Gas-pressure-regulated needleless injection system
CA1325149C (en) *	1989-08-31	1993-12-14	Gavin Mcgregor	Variable intensity remote controlled needleless injector
US5064413A (en) *	1989-11-09	1991-11-12	Bioject, Inc.	Needleless hypodermic injection device
US5062830A (en) *	1990-04-04	1991-11-05	Derata Corporation	Dry disposable nozzle assembly for medical jet injector
US5383851A (en) *	1992-07-24	1995-01-24	Bioject Inc.	Needleless hypodermic injection device

1992
- 1992-07-24 US US07/920,106 patent/US5383851A/en not_active Expired - Lifetime
1993
- 1993-07-23 CA CA002140772A patent/CA2140772C/en not_active Expired - Lifetime
- 1993-07-23 US US08/097,266 patent/US5399163A/en not_active Expired - Lifetime
- 1993-07-23 AU AU47827/93A patent/AU676490B2/en not_active Expired
- 1993-07-23 DE DE69327165T patent/DE69327165T2/de not_active Expired - Lifetime
- 1993-07-23 AT AT93918344T patent/ATE187083T1/de not_active IP Right Cessation
- 1993-07-23 JP JP50471494A patent/JP3633615B2/ja not_active Expired - Lifetime
- 1993-07-23 WO PCT/US1993/006940 patent/WO1994002188A1/en not_active Ceased
- 1993-07-23 EP EP93918344A patent/EP0651663B1/de not_active Expired - Lifetime
1995
- 1995-03-21 US US08/407,867 patent/US5520639A/en not_active Expired - Lifetime
2003
- 2003-12-24 JP JP2003426219A patent/JP2004141667A/ja active Pending

Also Published As

Publication number	Publication date
JPH07509161A (ja)	1995-10-12
US5383851A (en)	1995-01-24
US5399163A (en)	1995-03-21
WO1994002188A1 (en)	1994-02-03
EP0651663A4 (de)	1995-08-30
AU676490B2 (en)	1997-03-13
DE69327165T2 (de)	2000-08-24
CA2140772A1 (en)	1994-02-03
CA2140772C (en)	2006-07-11
EP0651663B1 (de)	1999-12-01
JP2004141667A (ja)	2004-05-20
DE69327165D1 (de)	2000-01-05
EP0651663A1 (de)	1995-05-10
JP3633615B2 (ja)	2005-03-30
AU4782793A (en)	1994-02-14
US5520639A (en)	1996-05-28

Legal Events

Date	Code	Title	Description
2000-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69327165D1 (de)	2000-01-05	Verfahren für nadellose subkutaninjektionen
CA1166537A (en)	1984-05-01	Vacuum-compression injector
US5370630A (en)	1994-12-06	Device for injection of fluidic materials into body tissue
DK0821600T3 (da)	2004-04-13	Selvskyllende angiografisk injektor
EP0879609A3 (de)	1999-06-02	Zweistufiger Druckstrahlinjektor
WO1993003780A1 (en)	1993-03-04	Injection syringe
DE60336940D1 (de)	2011-06-09	Medizinisches Injektionsgerät
WO1994002188A9 (en)	1994-03-31	Needleless hypodermic injection methods and device
ATE235931T1 (de)	2003-04-15	Druckstrahlinjektor
MX9801372A (es)	1998-11-29	Impulsor de jeringa de multiples dosis.
CA2148173A1 (en)	1996-01-16	Delivery Device for Injectable Materials
GB9100819D0 (en)	1991-02-27	Subcutaneous injector
US3130723A (en)	1964-04-28	Multidose jet injector
ATE478604T1 (de)	2010-09-15	Angiographische injektoranordnung
EP1229950A4 (de)	2003-03-05	Interdermales injektionssystem zum injizieren von auf dna beruhenden injektionsstoffen in den menschen
AU2003209095A1 (en)	2003-09-04	Intradermal injector
WO2003068296A3 (en)	2003-10-16	Needleless injector
EP0830868A3 (de)	1998-05-13	Vorgefüllte Spritze für medizinische Zwecke
CA2481434A1 (en)	2003-10-23	Needleless syringe for the subcutaneous injection of droplets of liquid substances
WO2001013975A3 (en)	2001-09-07	Dna-based intramuscular injection system for humans
EP0316428A4 (de)	1989-10-16	Verteiler einer hypodermischen flüssigkeit.
DE3875935D1 (de)	1992-12-17	Kraftstoffeinspritzpumpe.
CN86206138U (zh)	1987-05-27	无针注射器
US3955490A (en)	1976-05-11	Injection system for meat products
SU1271524A1 (ru)	1986-11-23	Безыгольный инъектор